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Introduction 
The problems of suicide and self-harm are universal to 
humanity (1-4).  However, the patterns and magnitude of this 
behaviour differ starkly between regions(4). 
Whereas the suicide rates are comparatively low in the West, 
recent reports from the developing world have revealed alarming 
results, with a prevalence several-fold higher than those described in 
western literature(5-8). 
Additionally whereas suicide in the West is more common 
among middle aged people, correlating strongly with psychiatric 
morbidity(4), seminal research in the very recent past has discovered 
that the picture of suicides seen in the developing world is entirely 
different. Suicide in these regions is more common in the young, and 
often occurs in the absence of major psychiatric disease. Rather, it is 
the presence of severe adversity, coupled with inordinate ease of 
access to highly lethal implements, most commonly toxic pesticides, 
that impels such catastrophe, even among the non-psychiatrically ill. 
(8-11). 
Interestingly, however, the overall rates of self-harm behaviour 
seem to be pervasive internationally (12), suggesting that the 
mortality in the developing world is a result of increased progression 
of impulsive self-harm to completed suicide. 
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As this new paradigm of suicidal behaviour, completely unlike 
the western pattern, has been recently suggested in studies from 
India and the developing world, further evidence to corroborate the 
same is desirable. Of particular interest is whether the actual attempt 
of suicide was the result of psychiatric morbidity, or the impulsive 
result of severe socio-cultural or economic stress.   
Also, while previously attention was duly given to common 
groups of poisons, such as organophosphorous and plant poisons, 
the constellation of poisons remaining, have not been fully 
characterized. These may be broadly grouped as non-
organophosphorous pesticides, prescription drug over dosages, and 
other chemical/corrosive agents. These form the large bulk of 
poisonings seen at an urban setting, whereas the former are common 
in rural regions.  
Further information regarding the utilization of treatment and 
first aid, as well as outcomes, requires delineation. 
To address the above lacunae, this prospective hospital-based 
clinical descriptive study was designed, with the motive of describing 
the profile of the above group of poisons, at a tertiary care South 
Indian referral hospital, over a six month period.
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Aim and Objectives 
Aim 
To describe the profile of poisonings due to non-organophopsphrous 
pesticide, prescription drug, corrosive and other chemicals, with 
respect to demographic characteristics, clinical presentation, treatment 
modalities, outcomes and psychiatric profile. 
Objectives 
Primary objectives 
1. To describe the demography and list the various poisons 
encountered in each group. 
2. To appraise differences in the profile of the various poison 
groups by performing an inter-group comparison. 
Secondary objectives 
1. To describe the various toxidromes, in terms of clinical and 
laboratory profile, and the resultant complications. 
2. To describe the motivation for poison consumption- in terms of 
intentionality, degree of premeditation and psychological 
distress (using the GHQ (General Health Questionnaire) 12 
score). 
3. To define the psychiatric profile of the patients encountered (as 
per assessment of the psychiatrist consulted). 
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4. To describe the therapeutic strategies administered i.e, gastric 
lavage rates prior to and at hospital presentation, intubation and 
ICU admission rates. 
5. To determine the rate of hospital ward admission and mortality. 
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Self-harm and suicide: a worldwide concern 
    The estimated global burden of suicide is around one million 
deaths per year, with an estimated annual mortality of 14·5 deaths 
per 100 000 people (one death every 40 seconds). It is also the tenth 
leading cause of death worldwide (1). In the year 1990 alone, there 
were 798,000 deaths due to self-harm, of which 75% were 
poisonings. (2) In 2000, 500,000 people died from self harm in South 
East Asia and the western pacific alone.(13) The rates of suicide 
worldwide are also shown to be increasing.(3) 
 However, there is in addition the wider problem of intentional 
self-harm among those who do not intend to die, which comprises a 
broad group of patients with a variable psychological profile. This 
perplexing disorder is a highly prevalent problem, has been found to 
be most common in adolescents and young people. This has also 
been found to have a consistent profile cross nationally. (14) Up to 5-
9 percent of adolescents in western countries report history of self-
harm in the preceding year.(12) The incidence appears to be 
increasing. However, true community based prevalence of this data is 
lacking, and hospital based reports of these may represent the “tip of 
the iceberg”.  
The risk of completing suicide also appears to be higher in this 
population.(15) Recent follow up studies have shown that those with 
a history of self-harm are at an increased risk of psychiatric illness 
later in life, including increased risk of suicidal behavior (16). 
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Therefore, special care needs to be addressed to identify and 
address the needs of this group. 
 
Epidemiology of self-harm and suicide 
worldwide: the East- West divide 
 
 There are differences in the definition of suicide internationally. 
This leads to different reporting rates of suicide between countries. 
Also, there may be questionable efficiency of reporting in some parts 
of the world. But despite this, there appear to be regional similarities 
in the profile and motives behind such behavior as well as broad 
differences between them internationally. 
This pattern appears to be nearly bipolar, with the developed 
Western world having a lesser burden and more favorable outcomes, 
while in the developing world, the prevalence is several times higher, 
with far more tragic consequences(4). The reasons for this difference 
are predominantly the choice of method used for self-harm, and the 
ability of the healthcare system to respond to the problem. 
 In the developed world, the overall incidence of suicide 
appears to be stable, or on the decline. In a European survey from 
1861-2007, suicide rates increased in all age groups in the 1930s, 
coinciding with the Great Depression, but in the 21st century the 
recorded rates were the lowest ever.  The highest male rates (30.3 
per 100 000) were recorded in 1905 and 1934 and have since been 
declining, whereas female rates peaked in the 1960s (11.8 per 100 
000), declining afterwards. The male-to-female sex ratio fluctuated 
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from 4: 1 in the 1880s to 1.5: 1 in the 1960s, being consistently higher 
in the males. (17) In contrast to suicide, however, the prevalence of 
self-harm is still high.(12)  
In the UK, the number of completed suicides, as calculated 
from coroners reports in three jurisdictions from 1 January 2001 to 31 
December 2001 only around 214 of which 49 (23%) reached hospital 
alive. Extrapolating this data to all England, there were around 300 
self-poisoning suicides per year to reach hospital alive, and around 
1300 completed suicides from poisoning nationally (6% of all 
suicides). (18) 
 In the US, the picture is has some similarities; with relatively 
low prevalence of suicide.  Possession of a firearm has been strongly 
linked to suicide in this population (19), but suicidal poisonings have 
increased with time. The population suicide rate hovers at 
approximately 10 - 12 per 100,000 population members. However, 
the distribution tends more toward younger age and female sex. 
Thus, there is a lower prevalence of both self-harm and suicidal 
deaths in the developed world, though it is still an important cause of 
death in the young. 
In contrast, patterns of suicide in the developing world offer a 
starkly different picture.  Sri Lanka is a developing country where the 
population is predominantly agricultural.  Based on coroner reports, 
the rate of suicides was as high as 48.7 per 1,00,000 in 1995, which 
had improved to 23 per 1,00,000 in 2006 (these may be an 
underestimate). The single largest cause of death was due to 
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poisonings (44%), while self-immolation accounted for 36%, and 
hanging, 7%. The reasons cited were predominantly emotional and 
marital conflicts, with psychiatric illness accounting for only 6%.(20) In 
another three-month study period (Aug-Oct 97) period covering three 
districts, there were 499 suicides in this population. A psychological 
autopsy was performed on these cases by interviewing contacts. The 
findings revealed that the majority of suicide deaths were due to 
pesticide ingestion (70%). 62% of deaths occurred in the hospital, 
implying that extremely lethal methods were used, which were 
refractory to therapy, and that services were ill-equipped to handle 
them. There was also a high proportion of psychiatric morbidity and 
substance abuse, with nearly one fourth having previously attempted 
self-harm, and one fifth with a family history of suicide.(21) In yet 
another study, 84% of attempted suicides were due to intentional self-
poisoning. The case fatality rate was around 18%, with certain groups 
of poisons being maximally implicated. (5) Sri Lanka has also been 
found to have the highest incidence of deliberate burns cases in the 
world.(22) 
Self-harm though is a far more prevalent disorder, even in the 
West. Between 5-9% of Australian, British and American teenagers 
report a history of self-harm in the preceding year(23-25).There has 
been a huge increase particularly in drug poisonings, after the 
emergence of the pharmaceutical industry in the 1960’s. From 2000 
to 2008, as per US National Poison Data System (NPDS) data, there 
were 1,672,324 suicidal exposures to substances, the majority (65%) 
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being female. The highest events were reported in the age groups 
13–19 and 20–29 years (26.4% and 25.7%, respectively), with the 
average rate being around 30 years. The estimated rate of substance 
use in attempted suicide and suicidal death increased from 55.8 to 
67.9 per100,000 population (p for trend <0.001) and from 72.6 to 82.8 
per 1000 human exposure cases, respectively. (26) In other parts of 
the developing world as well, it appears that self-harm has a similar 
profile, though reports are scarce. A retrospective hospital based 
review from Karachi, Pakistan, reported the mean age to be around 
23.5 years, with a female predominance. The majority reported 
poisoning with drug ingesti ons. (27) In Trinidad, a rise in male cases 
was noted, with women preferring tablets, while men used violent 
means.(28) 
In summary, while most developed western countries have 
relatively low and stable rates of complete suicides, the rates are 
extremely high in the developing world, with a larger number of 
younger and female suicides. On the other hand, self-harm rates are 
still high across the globe. The reasons for this disparity are explored 
subsequently. 
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Influence of demography on suicide and self-
harm 
Suicide rates and self-harm rates vary demographically. 
Certain demographic characteristics have been found to have 
consistent relationships with suicidal and self-injurious behavior. In 
the West, self-harmers appear to be a different demographic group 
from persons who complete suicide.  However, in the east, there 
appears to be an overlap between the self-harmers and those who 
progress to complete suicides. This may be due to increased 
translation into completed suicide, in view of use of extremely lethal 
implements. 
Age: In most countries, suicide rates are higher in the elderly, 
although in some developing countries the rates in the young are 
increasing.(29) In India, older men were more likely to commit suicide 
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than younger men.(30) As per western data, self-harm is rare before 
puberty, increasing in prevalence through adolescence and being 
most common among young adults in the second decade for men 
and the third decade for women.(31) Self-harm at older age is a 
marker of high risk. Younger individuals are more likely to have had a 
low risk unplanned suicide event. There was also a trend for severe 
medical outcome with increasing age in various studies(26,5).The 
age profile of suicide in India appears to parallel the profile of self-
harmers in the west.(6). 
Sex: The risk was found to vary with the population studied. 
Generally speaking, the risk of suicide is higher in males in the West. 
The ratio has been shown to vary between 2 and 4 to 1, whereas 
females are at increased risk in the east (32).  Female sex was 
associated with low planned suicide attempts in China, whereas in 
Brazil, the odds for repeat attempt were found to be higher in the 
female sex. (OR = 2.7; 95%  CI = 1.2-6.2).   In the US, as per the 
NPDS database, the female to male relative risk of exposure to 
poisons is 1.82. However, females were also 0.82 times less likely to 
experience a severe medical outcome compared to males (95% CI: 
[0.81–0.83], p < 0.001). (26) In India, the overall hazard risk is lower 
for women; however, in the population age 15-24, the rates of suicide 
are found to be persistently higher among women.(30,7,8,33) 
Internationally, women have an increased risk of self-harm. In the 
west, girls who self-harmed were at increased risk for depressed 
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mood, disordered eating, and romantic involvement. Girls were also 
more likely to report having a current or past boyfriend.(12) 
Occupation : Farmers in India were found to have high prevalent 
rates of suicide. (34,35) In china, rural populations were three times 
as likely to commit suicide as their urban counterparts. (32,36) 
Suicide rates have been found to be high in unemployed people, 
thought the reasons for these associations are complex- substance 
abuse and mental illness may be co-incidental factors. Medical 
doctors and nurses, especially female, are a high-risk group, the 
rates being highest in anesthetists. Access to poisons is probably the 
main permeating factor here (37-39). Housewives were found to be at 
increased odds for self-harm in some populations (e.g.: Brazil: OR = 
3.8; 95% CI = 1.2-11.8) (40) 
Other  factors: Being divorced, being unemployed or suffering from 
socio-economic disadvantage are also other demographic risk factors 
for self-harm. (12) Low socioeconomic status: Has been associated 
with suicide in some settings. (41)  
 
Psychopathology and contributory factors for 
suicide and self-harm 
 
People have engaged in self-injury for thousands of years.  
Self-harmers represent a distinct group of individuals; although a 
subset of these include those who attempt suicide, the vast majorities 
of these have no intention or wish to die. (42,43), While many of the 







well, not all 
who commit 
self-harm 
are at risk of 
suicide. 
Intent 
When interviewed, only a small minority (approximately 8%) of 
individuals with deliberate self-harm, expressed a desire to 
permanently end their lives.  (44) Some alternative reasons 
expressed for the act of self-harm included 'seeking help', 42% 
'escaping from the situation', 52% 'obtaining relief from a terrible state 
of mind' and 19% 'trying to influence someone' (43) 
Some of these range from minor injuries such as self inflicted 
cutting or carving, while some may adopt methods that appear to 
express a desire to end one’s life. However, self-harm is often 
impulsive.  
A study on the factors behind deliberate self-burning showed 
that the reasons included psychiatric illness, personal (including 
faith/religion) and political motivation. The self-immolators appeared 
to be a distinct group from the self-mutilators.(22) 
Fig 2. Skegg, K., 2005. Self-harm. The Lancet, 366(9495), 1471-1483. 
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Suicide, 
though, is never 
the result of one 
single stressor, but 
the end result of 
the culmination of 
numerous 
contributory factors. 
These may be 
classified as proximal - distal factors, or the diathesis-stress model.(4) 
These are listed below in further detail. 
 
(4) Hawton, K. & van Heeringen, K., 2009. Suicide. Lancet, 373(9672), 1372-1381.   
 
Distal (diathesis) Proximal (acute stressor) 
• Genetic loading • Psychiatric disorder 
• Personality characteristics 
(e.g., impulsivity, aggression) 
• Physical disorder 
• Restricted fetal growth and 
perinatal circumstances 
• Psychosocial crisis 
• Early traumatic life events • Availability of means 
• Neurobiological disturbances 
(e.g., serotonin dysfunction and 
hypothalamic-pituitary axis 
hyperactivity. 
• Exposure to models 
Fig 3. Hawton, K. & van Heeringen, K., 2009. Suicide. Lancet, 373(9672), 
1372-1381. 
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Risk factors for self harm and suicide 
Psychiatric disease 
Psychological autopsy studies from Western data have revealed that 
the prevalence of psychiatric disease in those who kill themselves is 
extremely high- as much 90 %, and contribute as much as 47-74% of 
the population risk of suicide, being the single most important factor 
there. (45). In India, Axis 1 psychiatric disorders and family history of 
psychopathology were shown to have odds for suicide of 19.5 (CI, 
7.32-73.35) and 12.75 (CI, 4.69-48.59) respectively (46). However, 
recent reports from India have demonstrated that psycho-social 
distress, rather than psychiatric disease, are the predominant factors 
implicated in suicidal behavior. This “distress” may occur in persons 
secondary to adverse circumstances in social, cultural or economic 
domains. (47) In China as well, the picture may well be similar, as the 
prevalence of psychiatric morbidity among suicides was found to be 
much lower.(36) 
Amongst the psychiatric disorders implicated in suicide, the most 
common etiologies are affective disorders, followed by substance 
abuse and schizophrenia. (4) The risk associated with each disorder 
is detailed below (48) 
Depression: More than half of suicides meet criteria for depressive 
disorder. About 4% of persons with depression will commit suicide. 
Clinical predictors of suicide in people with major depressive disorder 
also include a history of attempted suicide, high levels of 
hopelessness, and high ratings of suicidal tendencies.(49) Higher 
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Beck depression inventory scores have been associated with 
increased risk (41) 
Bipolar disorder: about 15% of these patients die by suicide. Risk 
factors are previous self-harm, family history of suicide, early onset 
and increasing severity of the disorder, depressive symptoms 
(including hopelessness), mixed affective states, rapid cycling, co-
morbid psychiatric disorder, and misuse of alcohol or drugs.(50) 
Schizophrenia: The lifetime risk of suicide is about 4-5%. This risk is 
associated less with the core symptoms of schizophrenia, such as 
delusions and hallucinations, but more with depression and specific 
affective symptoms (such as, agitation, sense of worthlessness, and 
hopelessness)(51) 
Other disorders associated with increased risk of suicide 
include anorexia nervosa, attention deficit hyperactivity disorder, body 
dysmorphic disorder, borderline and antisocial personality disorder, 
especially if co-present with affective disorders and substance abuse. 
Anxiety and panic disorders and adjustment disorders are also at 
increased risk. 
Substance abuse: notably ethanol addiction (41),  and smoking, 
have shown an increased risk of suicide. Nicotine addiction has been 
shown to have  a dose response relationship to suicide. (52) Alcohol 
use has been linked to increased risk of suicide. In a subgroup 
analysis of the WHO/ISBRA (International Society for Biomedical 
Research on Alcoholism) trial, a cross sectional analysis, variables 
were found to correlate with increased suicidal risk independently 
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were - drinking status, depressive symptoms, adverse drinking 
experiences during alcohol consumption and bad experiences from 
drug abuse and antidepressant (this study interviewed alcohol 
dependants). (53) 
With regard to prevalence of psychiatric disorder among self-
harmers as a whole, some surveys showed a high prevalence of 
affective disorders- mainly depression, and also substance abuse, 
and anxiety disorder. Co-incidence of personality disorder was high- 
in nearly half the patients. (54) 
Apart from depression, other psychiatric diseases, such as 
antisocial behavior and substance dependence may be under-
recognized. Personality disorders, especially borderline personality 
disorder, are known to be common among self-harmers, particularly 
self-mutilators. (54,55).  Adjustment disorders may be missed when 
applying a diagnostic instrument in a crisis setting. 
Conversely, treatment with Lithium for Bipolar disorder, and 
Clozapine for schizophrenia, has been shown to reduce the risk of 
self-harm. With SSRI's controversy exists as to whether they increase 
the rates of self-harm, but recent reports have shown no such 
association.(56) Cognitive Behavioral therapy among adolescents 
with self-harm has been shown to be beneficial.(16) A psychiatric 
senior house surgeon on the team also is desirable, to plan for follow 
up and avoid unnecessary medical admissions.(57) 
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Social and familial characteristics 
Familial and childhood experiences: Family environment in 
childhood has been shown to affect self-harm in adolescence. 
Divorce and marital discord have been shown to increase risk, as has 
poorer maternal education, psychiatric illness in parents. Childhood 
sexual abuse has also repeatedly emerged as a risk factor for self-
harm. Maladaptive parenting and childhood maltreatment increase 
the risk, while good communication with parents is protective. (12,58) 
Family history of  suicide has been associated with increased risk of 
the same.  
Past sexual abuse: Previous history of sexual abuse in childhood 
has been found to be significantly implicated amongst suicides, 
especially among women, and may contribute to the community risk 
of suicide.(59) Familial transmission of suicidal behavior has also 
been shown to occur, especially in conjunction with sexual abuse.(4) 
Sexual orientation: Men and women with gay, lesbian or bisexual 
orientation are more likely to self-harm than heterosexuals.(60) 
Social isolation and support: Social support moderates the risk of 
self-harm in persons facing acculturalisation stress(12). In another 
study, a majority of self-harmers were noted to have a paucity of well 
functioning relationships.(61).  A survey from India also revealed that 
social isolation was a risk factor for self-harm.(9) 
Religion: Persons from a Roman-Catholic affiliation were less likely 
to have attempted serious suicide.(62) Moral objections have clearly 
been a factor against self-harm in depressed patients. Strong 
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disapproval of suicide in some catholic and Islamic countries is a 
factor against self-harm. Increased availability of social support may 
be a factor. (63) 
Physical factors 
Chronic physical illness: A number of physical illnesses/conditions 
have shown increased risk of suicide. These are cancer (head and 
neck cancers in particular), HIV/AIDS, Huntington’s disease, multiple 
sclerosis, epilepsy, peptic ulcer, renal disease, spinal-cord injury, 
systemic lupus erythematosus, and pain.(64,65) 
Physical characteristics: Raised body-mass index has been found to 
be associated with increased risk of depression but reduced risk of 
suicide (15% decrease in suicide risk for each 5 kg/m² increase in 
body-mass index). This is a perplexing finding. Low cholesterol 
concentrations, which have been associated with increased suicidal 
risk, might play a part. On the other hand, height and suicide risk 
have been inversely related (a 5-cm increase in height was 
associated with a 9% decrease in suicide risk). (66,67) 
Other miscellaneous factors 
Major life events: Suicide rates have been shown to rise following 
major calamities such as earthquakes. Deaths of famous people have 
been historically linked to suicide. On the other hand, suicide rates 
decline in wars, possibly because of a greater sense of cohesion in 
society, and sense of purpose. (4) 
Neurobiological  and Genetic factors: Low concentrations of 5-
HIAA, a serotonin metabolite, have been found in the CSF of several 
   21 
 
patients who have self-harmed.(68) Blunted fenfluramine stimulated 
prolactin release, another index of altered serotonergic function, has 
been related to the seriousness of self-harm. Functional 
neuroimaging has indicated decreased binding of prefrontal 5-HT2A 
receptors in patients who have self-harmed. Twin and adoption 
studies have also shown a genetic link among those who have self-
harmed.(12) 
Self-harm that leads to suicide 
Around 40% of suicides have a past history of attempted self-
harm(45)More than five percent of people seen at a hospital for self-
harm will have committed suicide within nine years(12); in thirty 
years, 12% of a Swedish cohort of attempted suicides eventually 
successfully completed the act. (41) Therefore, self-harm is a strong 
predictor of suicide (4), with the risk being at its highest in the first 6 
months after a harming episode, (69) and which persists for many 
decades. Male sex, older age, and multiple episodes of self-harm 
have been identified as predictors of a later suicide. (70) Use of very 
lethal methods (implying strong wish to die) with concealment are 
additional risk factors. (12,71) In another study, independent 
predictors of risk in a multivariate model were: not living with a close 
relative, avoiding discovery at the time of self-harm, and current 
alcohol misuse. (69) In young people, another important predictor 
was previous psychiatric inpatient treatment. 12 
Therefore it appears that while the majority of self-harm is 
impulsive, among these individuals there is a significant number who 
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may progress to suicide, warranting heightened vigilance and 
preventive strategies. 
 
Disease, or distress? How suicidal behavior 
differs internationally 
Western literature cites the single most important precipitant of 
suicide to be psychiatric illness.(4) However, while this may be true in 
countries with low suicide prevalence, the scenario in the developing 
world suggests otherwise.(9) 
In some cultures, especially in the developing world, pesticide 
poisoning for self-harm has become a common response to stressful 
events. It is also used to convey a powerful message, targeted 
towards a specific individual, or the local community, conveying 
misgiving, anger, sadness, hopelessness and frustration, or simply a 
way to manipulate a situation to one's own advantage. (10) A 
qualitative study from India has also revealed that consuming 
poisoning is an accepted response to social distress.(72) 
In a previous report from Sri Lanka, it was noted that the majority of 
poisoning occurred with little premeditation and little knowledge about 
the lethality of the poison. Ease of access was cited as the main 
reason deciding the choice of poison. Most poisoning occurred within 
30 minutes of the decision to self-harm. Other similar studies have 
reported the reasons to be emotional distress due to a number of 
underlying factors, as responsible.  This supports reasoning that 
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poisoning acts are highly impulsive reactions to acute psychological 
distress.(10,73) 
 Recent reports from India have also challenged previous 
assumptions that the majority of suicides are linked to psychiatric 
disease. As most instruments are not geared to assess psychosocial 
distress as separate from severe mental illness, this leads to an 
inappropriate over diagnosis of the latter, and an under-
representation of adjustment disorders (individual with normal 
psychiatric coping mechanisms but facing an overwhelming stressor). 
(9) 
 Therefore, it appears that in the light of these new findings, a 
newer paradigm of suicidal behavior may have been unearthed. 
Further studies would aid to strengthen knowledge about the 
prevalence of this problem. 
 
The problem with pesticides and how to fix it. 
1·5 million tons of pesticides are manufactured every year, 
producing a business worth US$30 billion. (74) Although agricultural 
productivity improved in the 1950's with their widespread introduction, 
subsequently, a resurgence of pesticide-resistant pests, and the 
concomitant health and environmental costs are now glaringly 
evident. 
The WHO has classified their toxicity from class la (extremely 
hazardous) to class III (slightly hazardous) and then “active 
ingredients unlikely to present acute hazard”.(75) While most class I 
   24 
 
pesticides are banned in the industrialized world, their use is 
widespread in the developing world, where resources for safe use are 
lacking. 
These pesticides, though inexpensive, tend to be more toxic, 
from older generations, environmentally persistent and often non-
patented. There is lack of rigorous legislation to monitor the 
distribution and handling of these agents, and lack of personnel 
training on the careful use and potential side effects of these 
toxins.(76) Occupational exposures are also more common as it is 
impractical to use safety equipment in the humid tropics, and 
instructions may not be understood by illiterate farmers.(11) As a 
result, there is dangerous proximity to these agents in the domestic 
setting of the rural developing world. 
 The above statements are supported by evidence; in an 
extrapolation from very limited data, WHO estimates presume that 
three million pesticide poisonings may occur every year, with 220,000 
deaths.(77) In some parts of the developing world, this even outranks 
infectious disease as a cause of death. In a systematic review of 
literature on suicide, it was estimated that pesticides contributed to 
30% of all suicides globally; the estimated incidence of deaths from 
pesticide self-poisoning was 258,234 deaths per year.  (Plausible 
range 233,997 to 325,907) Corrected estimates (considering under-
reporting, especially in India) were closer to 371,594 (range 347,357 
to 439,267).(78) Also, the incidence of pesticide-associated mortality 
varies widely, ranging from 4% in Europe to 50% in the Western 
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pacific. Interestingly, the patterns of mortality and volume of pesticide 
sold did not correlate(79), therefore supporting the above hypothesis, 
that other factors- notably 
1. use of more toxic pesticides in developing countries, 
2. unsafe storage and distribution practices, and  
3. Lack of quality treatment for poisoning- may be the cause 
of this inequitable distribution of mortality. (78) 
The easy availability of pesticides may increase the lethality of 
deliberate poisonings with a low intent to die. In a psychological 
autopsy study among a Chinese population, low planned (impulsive) 
suicidal acts were more prevalent among women, younger individuals 
and those undergoing acute stress; pesticide consumption was also 
higher among this group.(36) 
In the 1980's, the adverse effects of unregulated pesticide us 
in the developing world was debated, and in response, the 
International Code of Conduct on the Distribution and Use of 
Pesticides was produced in 1985 by the UN Food and Agricultural 
Organization (FAO). Accordingly, manufacturers were requested to 
supply only pesticides of adequate quality, with packaging and 
instructions as appropriate for the target market. One element of the 
code states, 
".. pesticides whose handling and application require the use 
of uncomfortable and expensive protective clothing … should 
be avoided, especially in the case of small scale users in 
tropical climates” (Article 3.5). 
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Were this code followed, Class 1 pesticides would immediately 
be phased out in the tropics. Restricting the availability of pesticides 
has the ability to markedly reduce the rate of intentional self 
poisoning from the same.(80) Countries such as Argentina, Samoa, 
Jordan and Amman have all reported marked reduction in deaths 
following banning of toxic pesticides.(11) However, lack of political 
will combined with unavailability of resources to police the code, lead 
to widespread lapses in its implementation in other areas. 
The WHO in 1977 promoted the essential drugs list, to support 
rational drug use. Countries which subscribed to this have reported 
better supply and availability of their drugs,  33 The scenario with 
pesticides is similar, with hundreds of active ingredients and 
thousands of formulations are available in an uncontrolled fashion, 
promoted by both manufacturer and distributor as essential.  In this 
scenario, rational use is unlikely. Hence, the development of a 
minimum necessary pesticide list, using the least toxic agents 
possible, with appropriate precautionary usage measures, would 
certainly aid in legislation to phase out and ban toxic pesticides. In 
concomitance with other measures, such as farmer education, and 
integrated pest management that reduces the dependence on 
pesticides and stresses use of other techniques, the grisly scenario of 
pesticide related mortality may become a distant memory. 
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Epidemiology of self-harm and suicide in India 
India has the unhappy distinction of having alarmingly high 
rates of suicide and self-harm, several times above that of the 
developed world. 
The absolute number of deliberate self-burning cases in India 
is the highest in the world. India also has the highest admission rate 
for burns, and the highest fatality rates in the world (22) 
India also ranks among the highest reported suicide rates in the world 
as described below.(30,7,8,33) 
Prevalence of suicidal ideation and behavior in India 
In a study among adolescents in an urban setting, non-fatal 
suicidal behavior (defined as suicide attempt or suicidal ideation), 
was found to be extremely prevalent- with a lifetime risk of 21.7 % 
and 8.5% respectively. Risk associations on logistic regression 
analysis were found to be Hindu religion, female sex, being an older 
adolescent, physical abuse by parents, feeling neglected by parents, 
history of running away from school, history of suicide by a friend, 
death wish and deliberate self-harm. 
In another study in Chandigarh, Urban North India, Out of 
2402 students 1078 (45.8%) had psychological problems, 180 
(8.82%) students reported that life was a burden, 122 (6%) reported 
suicidal ideas and 8 (0.39%) students reported suicidal attempt.  
Perception of life as a burden was found to correlate with class 
studied, mothers working status, and problems experienced in 
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relation to study, peers, with future planning and in parental 
relationships.(81) 
A survey among primary health centers in rural west Bengal 
revealed that there were 89 cases of self-harm in three blocks, in the 
year 2002. Stressors were marital conflict or conflict with in-laws or 
guardian; 69.6% experienced more than one form of domestic 
violence. Poverty and unemployment in the family were strongly 
associated violence; husband (48.48%) followed by in-laws (16.67%) 
were the most common perpetrators among women, while parents 
were mostly responsible among men.(82) 
Nearly 1,50,000 Indian farmers committed suicide in nine 
years from 1997 to 2005, official data show. While the suicides 
occurred in many States, nearly two-thirds of such deaths were 
concentrated in five States where just a third of the country’s 
population lives with appalling intensity: these are Maharashtra, 
Andhra Pradesh, Karnataka, Madhya Pradesh (including 
Chhattisgarh) and Kerala. The rates in these states are also 
increasing (34,35) 
Before 2003, suicide rates in India, based on census and 
police records, were thought to vary between 8.1 and 58.3/100 000 
population for different parts of India. However, under-reporting was 
considered likely due to inefficient civil registration systems, poor 
reporting of deaths, variable standards in certifying death and the 
legal as well as social consequences of suicide. (83,84) 
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 The population of Kaniyambadi block in Vellore district, Tamil 
Nadu, which represents a rural population, with agriculture and 
animal husbandry as the main occupations, has been under 
surveillance by the Community Health Department of CMC Hospital 
Vellore for over fifteen years. The results of serial surveys in this area 
have provided insights into the local epidemiology and prevalence of 
poisonings in a rural setting in India. 
As early as 1994-99, a survey on this population (area 127 
km2; population 108 873 in 1999)) revealed alarming results.(30) The 
suicide rate was found to be extremely high- more than previously 
reported anywhere else in the world- 95.2/100 000 (range 83.7-
106.3/100 000). These accounted for between 8% (89/1057) and 
12% (112/940) of total deaths. 
Overall, females were 0.84 times as likely as men to commit 
suicide; however, among the young adults (15-24 years), suicides 
were more common among women (102/278 and 58/331 respectively 
for women and men). There was a bipolar distribution of suicides 
among women, mainly among the young adults and the very old 
(over 65 years). Older men were at higher risk of suicide than 
younger men.  
The methods of suicide used were poisoning, hanging, 
drowning or self-immolation. Women more often chose drowning or 
burning, while men often chose poisoning or hanging. People 
younger than forty-four years tended to use poison; whereas older 
people tended to choose hanging.  
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There was no significant change in the suicide rate with time 
during the period of survey. (30) 
A repeat survey published in 2004 using the verbal autopsy 
method in this same population showed the suicide rate among 
young people to still be extremely high, with a similar female 
predominance in the young-    148 per 100,000 in women, and 58 per 
100,000 in men (1992-2001, age group 10-19 yrs). These accounted 
for about a quarter of all male deaths, and three-quarters of all female 
deaths, in their age categories.(7)  
In the subsequent repeat survey (1998-2004) in the same 
population the mortality rates due to suicide were 82.2 per 100,000 
population, with mortality in the age group 15-29 years, being 92.9 
and 99.8 for males and females respectively- somewhat improved 
from previously.  The majority were again hangings and poisonings. 
(258 / 638). Among poisonings, class I and class II pesticides were 
used most commonly. The relative frequency of poisonings to other 
methods of suicide remained unchanged over the 7 years of the 
study.(8) 
The latest survey (January 2006- December 2007) revealed a 
suicide rate of 120.3/100000 (130.9/100 000 in men, 109.7/100 000 
in women). In the age group 15-24, women predominated (148.5 vs. 
82.7 for men, RR 2.53 (1.47–4.35; χ2 = 12.92, P <0.01). (33).   
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Mode of self-harm and survival status among 252 cases  registered over a 24-month period 
in Kaniyambadi Block, India  (Bose et al, 2009) 
Means of self-harm Survived (%) Died (%) Total number of cases (%) 
Hanging 26 (24.3) 81 (75.7) 107 (42.5) 
Poisoning 64 (58.2) 46 (41.8) 110 (43.7) 
Drowning 4 (28.6) 10 (71.4) 14 (5.6) 
Burning 8 (40.0) 12 (60.0) 20 (7.9) 
Fall from height 1 (100.0) 0 1 (0.4) 
Total 103 (40.9) 149 (59.1) 252 
(33) 
 Similar results were also reproduced in another district of 
Tamil Nadu by using the verbal autopsy technique: the average 
annual suicide rate for men and women were 71 and 53/1,00,000 
respectively. Three-fourths of all suicides were in the socially and 
economically productive age group of 15–44 years. At ages 15–24 
years the female suicide rate of 109/1,00,000 exceeded the male rate 
of 78/1,00,000; suicide was responsible for 49% of all deaths in 
women and 38% of all deaths in men at these ages(85) 
Poisoning in India: case reports- a major contributor to self- 
harm and suicide 
Self-poisoning worldwide increased in popularity from the 
1860s (5% of suicides) to the 1990s (22% of suicides).(17) From 
India, there are only few studies describing the profile of patients 
presenting with poisoning. 
A retrospective review in children by Kohli et al from Delhi 
stated that Kerosene (27.9%), drugs (19.8%) and insecticides 
(11.7%) were the agents most frequently. Only a small number of 
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patients (3) developed serious illness requiring mechanical 
ventilation. (86) 
 A prospective review by Gargi et al in Amritsar, Punjab, 
revealed poisonings to account for 3.19% of emergency admissions. 
Males were more common (3:1). 45.59% were in the age group of 21-
30 years, 69.12% were married and 51.47% belonged to urban area. 
76.47% intended suicide at admission. Commonest poison was 
aluminum phosphide (38.23%) followed by organophosphorus 
compounds (17.64%). (87)  
A retrospective review in Mangalore, South India reported 
0.9% of total hospital admissions due to poisoning.  Common 
etiologies were pesticides (49%) followed by drugs (17%), and 
alcohols (13%). Forty-eight (15%) patients died. The poisons 
responsible for most of the mortality were organophosphate 
pesticides (65%) and aluminum phosphide (15%). (88) 
A retrospective review (1993- 1998) in Vellore revealed an 
occurrence of 1548 poisonings over 4 years at a tertiary care 
hospital, with mortality of 3.3%. Most commonly implicated etiologies 
were Kerosene in children and pesticides in adults, the latter 
accounting for the highest mortality. (89) 
The community based 2 year study in Kaniyambadi, Vellore by 
Bose et al (33) also revealed that poisonings were the second most 
common means of attempted suicide (43.7%). In addition to 46 
fatalities, there were 64 attempted poisoning suicides too. Pesticides 
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were the most common agent. Fatality was highest among the 
pesticide group, while minimum among drug over dosages. 




Per cent of all 
poisonings 
Number of deaths 
following self-poisoning 
Pesticides 68 61.8 36 
Poisonous plants 21 19.1 9 
Pharmaceuticals 18 16.4 0 
Other  2 4 1 
Unknown 1 1.8 0 
Total  110 0.9 46 
(33) 
From the above information, it appears that kerosene 
poisoning and other accidental poisons are more common in children; 
among adults, there is preferential use of phosphides in Northern 
India, while organophosphates and other insecticides, as well as 
poisonous plants are more common in the south; this is probably 
related to agricultural practice. 
 
Comparing suicidal behavior in India to Western 
Literature.   
The suicide rates in India are much higher in India as 
compared to the West. The majority of suicides in the West are 
related to psychiatric disease(45), while in the developing world, and 
especially in India, most suicidal attempts stem from impulsive 
behavior and stress.(9) The factors involved have a social, economic 
and cultural dimension. (90,72)  
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A qualitative study on the reasons and perceptions behind 
suicidal behavior cited a high prevalence of interpersonal and family 
problems, and especially marital discord, among the reasons for 
suicide.(72) 
Recent studies using the verbal autopsy method have 
described the reasons for suicidal behavior to be related to 
socioeconomic circumstances and to interpersonal, social and 
cultural conflicts. (91) Other studies via psychological autopsies have 
supported the conclusion that suicide is related to interpersonal 
conflicts, marital discord, alcoholism, financial problems and 
unemployment. (92) Previous studies in India have shown the 
association between adverse life events and suicide.(46) These 
findings among suicide parallel those with self-harm behavior. (82) 
Economic crises have also been found to be serious 
precipitants of suicidal behavior, especially among farmers.. As per 
the National Crime Records Bureau data (which may grossly 
underestimate the actual rate), the rate of suicide among farmers is 
on the increase. Farm suicides as a proportion of total suicides rose 
from 14.2 in 1997 to 15.0 in 2005. From 1997- 2005, there were over 
1.5 lakh officially reported farmer suicides. The ACGR (Annual 
compound growth rate) for all suicides in India over a nine-year 
period(1997-2005) was 2.18 per cent, but for farm suicides it is much 
higher, at nearly 3 (or 2.91) per cent; suicide by consuming pesticide 
was 2.5 per cent. The reasons for this disturbing trend are due to a 
debt trap, resulting from acute income depletion due to decrease in 
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the overseas market following changes in international policy, 
coupled with several hundred percent increase in cultivation costs, 
exhaustion of credit schemes and decrease in government 
subsidies.(34,35) 
Mental illness undoubtedly contributes to suicide(9,46,93); 
however, the contribution is less in India, where the above described 
factors have a much higher role to play. Also, there may be a 
tendency to over-report mental illness in psychological autopsy, 
owing to symptoms of the same being present in those who have 
suffered adverse life events; these do not necessarily reflect severe 
mental illness.(9,93)  
These findings are supported in a recent case-control study on 
risk factors for suicide in rural south India; Psychosocial stress and 
social isolation (break in a steady relationship, living alone) rather 
than psychiatric illness were found to be significant risk factors for 
suicide in this population: This supports the hypothesis that many in 
the general population in India view suicide as an option when faced 
with apparently insoluble personal difficulties or misfortune.(9)  
The role of mental illness as a contributor to suicide increases 
where the overall prevalence of suicidal behavior is low. The reasons 
for this apparent east-west divide include possibly, better social 
security schemes, religious beliefs, as well as economic and social 
transitions. (9)  
In summary, psychosocial distress from a number of social, 
economic and cultural factors probably account for the large number 
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of suicides in India as compared to the West, where mental illness is 
the principal contributory factor. 
The findings over the last several years generate certain 
hypothesis.   
1. The extremely high rates, age and sex profile of suicides are 
more consistent with the western pattern of self-harm behavior 
rather than that of suicide. This may imply that a higher rate of 
self-harm cases, especially among young people, progress to 
complete suicide. The reasons for this may be availability of 
extremely lethal agents such as pesticides, which when 
consumed even minimally, have high mortality. 
2. It is likely that the psychopathology and access to implements 
of suicide are different in the various groups.  
3. Among the adolescent and young group, certain social and 
cultural factors are more adverse to females, leading to the 
persistently elevated suicide rates among the young women as 
compared to men. These may be reduced literacy, 
employment and financial freedom, burden of home or family 
rearing, domestic physical, mental or sexual abuse.   
4. The increased likelihood of suicide among elder as compared 
to younger men are possibly due to debt, unemployment, or 
substance abuse, especially alcohol. 
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A brief review of different common poisons 
Pesticide poisons 
Pesticides: different categories(79) 
Insecticides Organochlorines, organophosphates, 
carbamates, pyrethrins, synthetic 
pyrethroids, nicotine, rotenone, 
microbiological (Bacillus thuringiensis) 
Herbicides Trichloro/dichlorophenoxyherbicides, urea 
derivatives, carbamates, triazines, 
glyphosate 
Fungicides Carbamates, organophosphates, 
miscellaneous compounds including 
captan, captofol, pentachlorophenol, 
iprodione, elemental sulphur, 
carbendazim* 
Antimicrobials Triazine-S-triones, chlorine-releasing 
agents, chlorine, dichloronitrobenzene 
Rodenticides Coumadin and derivatives, long-acting and 
short-acting anticoagulants, strychnine, 
sodium fluoroacetate, phosphorous 
compounds* 
*added to original list 
O'Malley, M., 1997. Clinical evaluation of pesticide exposure and 
poisonings. The Lancet, 349(9059), 1161-1166.   
Organophosphorous pesticides  
 Organophosphates poison the nervous system by 
inhibiting the enzyme-catalyzed breakdown of the neurotransmitter 
acetylcholine. This results in overstimulation of the parts of the 
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nervous system that contain acetylcholine-i.e. muscarinic post-
ganglionic fibers of the parasympathetic nervous system, sweat 
glands in the sympathetic nervous system, preganglionic fibers in the 
sympathetic nervous system, and skeletal muscle. Clinical features 
include miosis, urination, diarrhoea, diaphoresis, lacrimation, 
excitation of central nervous system [CNS] and salivation. Diagnosis 
of acute organophosphate poisoning is based on a history of 
exposure and a blood test of red-cell and plasma cholinesterase. 
Atropine reverses muscarinic symptoms of organophosphate 
poisoning for short periods. Delayed organophosphate neuropathy 
that presents 7–14 days after exposure, and is due to inhibition of 
neuropathy target enzyme inhibition (79).  The intermediate 
syndrome reported by Senanayake and Karalliedde  is distinguished 
from delayed neuropathy by onset within 24–96 h after recovery from 
acute cholinergic crisis, tendency for the cranial nerves and proximal 
muscles to be affected, and tetanic fade instead of denervation 
potentials on electromyography. Recovery was also faster, occurring 
over 4–18 days rather than 6–12 months as is typical of delayed 
neuropathy (94). No re-exposure should be allowed until 
cholinesterase activities have returned to baseline values. A meta-
analysis concluded that oxime therapy was found to have no effect on  
mortality rate, mechanical ventilation or incidence of intermediate 
syndrome. (95) 
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Carbamates 
Carbamates have activity similar to organophosphates, but of much 
shorter duration than that caused by equivalent doses of organophosphates, 
most recovering within 24 hours. This is because the complex between 
cholinesterase molecule and carbamate more readily breaks down, thereby 
obviating the necessity of new enzyme for restoration of function. A transient 
depression in S. Pseudocholinesterase levels may occur.(79) The mortality 
rates associated with exposure to these were found to be similar to 
organophosphates in some settings (96). Based on existing experience, 
atropine remains the treatment of choice and pralidoxime (2-PAM) is not 
recommended except in cases where atropine has first been proven 
inadequate, in serious mixed poisonings with both carbamate and 
organophosphorus compounds, or in serious poisonings by unidentified 
cholinesterase inhibitors. (97) Treatment with oximes is not recommended 
as it can exacerbate the effects of particular carbamates (carbaryl and 
propoxur). (79) 
Organochlorines 
DDT is the prototype compound. Symptoms of exposure are hyper-
excitability, tremulousness, and seizures, in extreme cases. 
Most compounds persist environmentally for years, and can even be 
measured in the body several months or years after substantial exposure. 
However, Endrin is an exception, undergoing rapid hepatic metabolism Toxic 
doses are generally lower, although higher with Endrin.  (Oral LD50 in rats 
113 mg/kg vs. 4–13 mg/kg for parathion).(79) They have also been 
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associated with increased risk of breast cancer, but these reports were 
unsubstantiated.(98) 
They are toxic to the central nervous system and sensitize the 
myocardium to catecholamines. Treatment involves supportive care and 
avoiding exogenous sympathomimetic agents. (99)  
Pyrethroids 
Pyrethrum is a partially refined extract of the chrysanthemum flower, 
which has been used for over 7 decades. They are less toxic to humans as 
they undergo rapid hydrolysis in the mammalian liver, the lethal dose 
therefore being high (ld50= 1500 mg/kg in rats). Synthetic pyrethoids are 
modifications of the pyrethrum molecule, to improve compound stability. In 
adult human beings, 10 mg/kg oral doses have been reported to cause 
seizures.(79) They can cause toxic effects to pulmonary and central nervous 
systems.(99) Two basic poisoning syndromes are seen. Type I pyrethroids 
produce reflex hyper-excitability and fine tremor. Type II pyrethroids produce 
salivation, hyperexcitability, choreoathetosis, and seizures. Both produce 
sympathetic activation. Systemic poisoning is rare in view of slow trans-
cutaneous absorption, and hence significant epidermal reservoirs may build 
up unawares. Carboxyesterase inhibitors enhance pyrethroid toxicity in 
experimental studies, hence unauthorized mixtures with organophosphate 
may enhance toxicity. Pentobarbitone is effective probably due to its dual 
action as chloride channel antagonist and membrane stabilizer.  Acute 
poisoning requires supportive care only. Allergic manifestations were 
common with earlier, less refined preparations. (100) 
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Dipyridyls 
Ingestion of paraquat causes severe inflammation of the throat, 
corrosive injury to the gastrointestinal tract, renal tubular necrosis, hepatic 
necrosis and pulmonary fibrosis. Administration of oxygen should be avoided 
as it produces more fibrosis. Bentonite and fuller's earth should be used to 
treat dipyridyl poisoning. If neither is available, activated charcoal is an 
acceptable substitute. After administration of absorbents, sorbitol catharsis is 
recommended. (79) Use of immunosuppressive agents have improved 
outcome in patients with paraquat poisoning. (99) 
Rodenticides 
Rodenticides include Coumadin and derivatives, long-acting and 
short-acting anticoagulants, (superwarfarins), strychnine, sodium 
fluoroacetate, thallium, barium carbonate and phosphides (aluminum and 
zinc phosphide).  
Alopecia is an atypical feature of thallium toxicity. (99) 
Most exposures to superwarfarins are harmless but prolonged 
bleeding may occur. (99) 
 Barium carbonate Ingestion can cause severe hypokalaemia and 
respiratory muscle paralysis. (99) 
Aluminium phosphide is a highly toxic agent with mortality ranging 
from 37% to 100%. It inhibits mitochondrial cytochrome c oxidase and leads 
to pulmonary and cardiac toxicity. Treatment is supportive with some studies 
suggesting a beneficial effect of magnesium sulphate (99). However, failure 
of cellular respiration is also likely to be due to a mechanism other than 
inhibition of cytochrome C oxidase. In addition, phosphine and hydrogen 
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peroxide can interact to form the highly reactive hydroxyl radical and 
phosphine also inhibits catalase and peroxidase; both mechanisms result in 
hydroxyl radical associated damage such as lipid peroxidation (101). The 
major lethal consequence of phosphide ingestion, profound circulatory 
collapse, is secondary to factors including direct effects on cardiac 
myocytes, fluid loss, and adrenal gland damage. In addition, phosphine and 
phosphides have corrosive actions. (101) Phosphine-induced impairment of 
myocardial contractility and fluid loss leads to circulatory failure, and 
critically, pulmonary edema supervenes, though whether this is a 
cardiogenic or non-cardiogenic is not always clear. Metabolic acidosis, or 
mixed metabolic acidosis and respiratory alkalosis, and acute renal failure 
are frequent. Other features include disseminated intravascular coagulation, 
hepatic necrosis and renal failure. There is conflicting evidence on the 
occurrence of magnesium disturbances. There is no antidote to phosphine or 
metal phosphide poisoning and many patients die despite intensive care. 
Supportive measures are all that can be offered and should be implemented 
as required. (101) 
Ethylene dibromide-a highly toxic, fumigant pesticide-produces oral 
ulcerations, followed by liver and renal toxicity, and is almost uniformly fatal. 
(99) 
Plant poisons 
In parts of the developing world, plant poisoning is a major 
clinical problem. Poisoning with Thevetia peruviana (yellow oleander), 
Datura stramonium, Cerbera manghas (pink-eyed cerbera or sea 
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mango, and Cleistanthus collinis (a species of teak) cause a 
significant numbers of deaths each year in south Asia. (102,73) 
Oleander: In some areas, 40% of self-poisoning cases are now linked 
to oleander seeds, particularly in teenagers, with an annual incidence 
of more than 150 per 100 000.(102) Almost all deaths result from 
suicide or homicide. 
All parts of these plants are toxic, and contain a variety of 
cardiac glycosides including neriifolin, thevetin A, thevetin B, and 
oleandrin.  Ingestion of sufficient quantities of any part of the common 
(Nerium oleander) or yellow (Thevetia peruviana) oleander can 
produce a syndrome similar to digoxin poisoning. Clinical features 
include nausea, vomiting, abdominal pain, diarrhoea, dysrhythmias, 
and hyperkalemia. In most cases, clinical management of poisoning 
by either N. oleander or T. peruviana involves administration of 
activated charcoal and supportive care.  (103) Anti-digoxin Fab 
rapidly and safely reverses yellow oleander-induced arrhythmias, 
restores sinus rhythm, and rapidly corrects bradycardia and 
hyperkalemia.(102)  However, these are not widely available due to 
prohibitive costs. 
Cleistanthus collinus: Cleistanthus collinus (local name: oduvan) 
poisoning is a common suicidal poisoning method used in rural 
southern India. Common signs and symptoms included hypokalemia, 
vomiting, hyponatremia, altered sensorium, bradycardia and 
abnormal ECG. Common signs and symptoms included hypokalemia, 
vomiting, hyponatremia, altered sensorium, bradycardia and 
   44 
 
abnormal ECG. Tests of renal tubular function reveal a normal anion 
gap, hyperchloremic, metabolic, defective urinary acidification, and 
hypokalemia with kaliuresis, indicative of distal renal tubular acidosis. 
Urinary hexosaminidase and amino acid levels, markers of proximal 
tubular dysfunction, are elevated.(104)  case fatality rate is 30%. The 
median time to death after oduvan ingestion is 3 days. (105) Other 
complications include ARDS, distal renal tubular acidosis and 
distributive shock secondary to inappropriate vasodilatation (106) A 
neostigmine responsive myasthenia like crisis in the absence of 
hypokalemia has been reported. (107) Use of boiled oduvan extract is 
associated with an increased mortality (HR: 2.71, 95% CI: 1.17-6.32) 
compared to ingesting fresh leaves. (105) 
Pharmaceutical poisons 
The true incidence drug poisoning worldwide is not known due to 
under-diagnosis and under reporting. An estimated 2-5 million cases occur 
annually in the US alone. (108,109) Overall mortality rates are around 0.05 
%, but in hospital mortality rates are 1 – 2 percent (110).  Poison exposures 
account for 5- 10 % of all emergency department visits, and more than 5 % 
of adult ICU admissions in the US. The annual incidence of poisoning is 
increasing (108). A rising incidence of prescription drug over dosages has 
been noted in recent years. This is mainly attributed to prescription opiod 
analgesics, cocaine, and psychotherapeutics, while illegal drugs such as 
heroin and methamphetamines. Optimal management of the poisoned 
patient depends upon the specific poison(s) involved, the presenting and 
predicted severity of illness, and elapsed time between exposure and 
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presentation. Treatment variably includes supportive care, decontamination, 
antidotal therapy, and enhanced elimination techniques. 
Antidote administration is appropriate when there is a poisoning for 
which an antidote exists, the actual or predicted severity of poisoning 
warrants its use, expected benefits of therapy outweigh its associated risk, 
and there are no contraindications. Antidotes dramatically reduce morbidity 
and mortality in certain intoxications, but they are unavailable for most toxic 
agents and therefore are used in only about 1 percent of cases. 
Psychotropic agents 
Tricyclic antidepressants: Patients who are symptomatic (e.g., weak, 
drowsy, dizzy, tremulous, palpitations) after a TCA overdose require 
emergency referral. Toxic doses: For all TCAs except desipramine, 
nortriptyline, trimipramine, and protriptyline, the dose is >5 mg/kg. For 
despiramine it is >2.5 mg/kg; for nortriptyline it is >2.5 mg/kg; for 
trimipramine it is >2.5 mg/kg; and for protriptyline it is >1 mg/kg.(111) 
On ECG, a wide-complex arrhythmia with QRS duration longer than 
100 msec is an indicator that the patient should be immediately 
stabilized, given sodium bicarbonate. Symptomatic patients with TCA 
poisoning might require prehospital interventions, such as 
intravenous fluids, cardiovascular agents, and respiratory support, in 
accordance with standard ACLS guidelines (Grade D).  
Administration of sodium bicarbonate might be beneficial for patients 
with severe or life-threatening TCA toxicity if there is a prehospital 
protocol for its use (Grades B/D). 12) For TCA-associated 
convulsions, benzodiazepines are recommended (Grade D). (111) 
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Atypical antipsychotics: Toxic doses of various atypical antipsychotics 
are as follows:  aripiprazole 15 mg, clozapine 50 mg, olanzapine 10 
mg, quetiapine 100 mg, risperidone 1 mg, ziprasidone 80 mg. 
Patients who use atypical antipsychotic medications on a chronic 
basis can be observed at home unless they have acutely ingested 
more than 5 times their current single dose Continuous cardiac 
monitoring should be implemented given reports of conduction 
disturbances associated with this class of medications. Provide usual 
supportive care en route to the hospital, including airway 
management and intravenous fluids for hypotension 
Selective serotonin reuptake inhibitors: Mild effects include vomiting, 
somnolence [lightly sedated and arousable with speaking voice or 
light touch], mydriasis, or diaphoresis. Toxic doses are- citalopram 
100 mg, escitalopram 50 mg, fluoxetine 100 mg, fluvoxamine 250 mg, 
paroxetine 100 mg and sertraline 250 mg. The use of oral activated 
charcoal can be considered; however, there are no data to suggest a 
specific clinical benefit. Intravenous benzodiazepines for seizures and 
benzodiazepines and external cooling measures for hyperthermia 
(>104 degrees F [>40 degrees C]) are recommended for SSRI-
induced serotonin syndrome.(112) 
Paracetamol 
Clinical signs include repeated vomiting, right hypochondrial 
tenderness or mental status changes. Activated charcoal can be 
considered is less than 2 hours have elapsed (Grade A). The toxic 
dose is around 10 grams or 200 mg/kg, for those above 6 years 
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age.(113) N-Acetyl cysteine is protective when given within the first 
eight hours after ingestion.(114) It also reduces mortality when 
administered after the onset of hepatic failure.(115)  S. 
Acetaminophen should be checked at 4 hours post ingestion, or the 
earliest possible thereafter. No evidence of toxicity at 36 hours 
permits discharge. 
A retrospective study has identified clinical and laboratory predictors 
of ICU admission. This has not been validated in our setting (116) 
There is no data on the spectrum of tablet poisoning seen in India. A 
pilot study from our hospital has revealed that drug over dosages accounts 
for 18.7 % of hospital admissions for poisoning.  
Corrosive and caustic ingestion 
Caustic ingestion can cause severe injury to the esophagus and 
the stomach. The severity and extent of esophageal and gastric 
damage resulting from a caustic ingestion depends upon the 
following factors (117,118) 
1. Corrosive properties of the ingested substance  
2. Amount, concentration, and physical form (solid or liquid) of the agent  
3. Duration of contact with the mucosa  
Most ingestion occurs in children and the remainder in psychotic, 
suicidal, and alcoholic subjects. More than 5000 caustic ingestions 
are reported annually in the United States (119).  
A study comparing outcomes of acid (mostly glacial acetic acid) or 
alkali ingestion found that outcomes were overall worse for those who 
ingested acid (120).  Such patients had significantly more severe 
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mucosal injury, were more likely to be hospitalized in the intensive 
care unit, to have systemic complications or perforation, and had 
higher mortality. 
Alkali ingestion (such as ammonia or sodium hydroxide) acutely 
results in a penetrating injury called liquefactive necrosis. The injury 
extends rapidly (within seconds) through the mucosa and wall of the 
esophagus towards the mediastinum until the alkali is buffered by 
tissue fluids. In the stomach, partial neutralization of the ingested 
alkali by gastric acid may result in a more limited injury. Extensive 
transmural damage may result in esophageal, gastric, or duodenal 
perforation, mediastinitis, peritonitis, and death. Esophageal 
carcinoma is a delayed complication, occurring up to forty years later 
(121,122) 
The clinical features of caustic ingestions vary widely. Early signs 
and/or symptoms may not correlate with the severity and extent of 
tissue injury (123). Patients may complain of oropharyngeal, 
retrosternal or epigastric pain, dysphagia/odynophagia, or 
hypersalivation. Persistent severe retrosternal or back pain may 
indicate esophageal perforation with mediastinitis. Other findings that 
may occur include vomiting, hematemesis, and persistent, localized 
abdominal tenderness, rebound, and rigidity which may indicate 
esophageal or gastric perforation with peritonitis. Caustic injury to the 
oropharynx causes pain and inability to clear pharyngeal secretions 
with persistent drooling. 
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Hoarseness, stridor, aphonia and respiratory difficulties are less 
common and result from caustic burns of the epiglottis and larynx. 
Pulmonary aspiration leads to dyspnea. Fever, tachycardia, and 
shock generally imply the presence of more severe and extensive 
injury (124). 
A grading system for esophageal injury to predict subsequent 
clinical outcome has been developed based upon a study of 81 
patients with corrosive ingestion (125). 
• Patients with grades 1 and 2A have an excellent prognosis 
without significant acute morbidity or subsequent stricture 
formation.  
• Patients with grades 2B and 3A develop strictures in 70 to 
100 percent of cases.  
• Grade 3B carries a 65 percent early mortality and the need 
for esophageal resection with colonic or jejunal 
interposition in most cases. Injury should have nasoenteric 
tube feeding initiated after 24 hours. Oral liquids are 
allowed after the first 48 hours if the patient is able to 
swallow saliva.  
Steroids or antibiotics are not recommended (125). A 
prospective randomized trial of corticosteroid therapy for caustic 
ingestion in children confirmed that stricture formation is directly 
related to the depth of initial injury. In severe burns, corticosteroids do 
not protect against stricture formation and may produce serious side 
effects.(126) 
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Rationale for this study 
  In the light of the information above, the problem of suicidal 
mortality and morbidity, especially with respect to poisonings, is well 
established. Although community based surveillance has shed light 
on the means and methods as well as the prevalence poisonings, 
further knowledge is required. Also, comparing the demographic 
profile, motives and agents consumed of patients reaching hospital 
with those in the community may provide valuable information about 
health seeking behavior, and unmask impediments to accessing 
timely health care. 
Bose et al proved that survival is significantly better for those 
who access treatment within the first 4 hours. Therefore accurate 
quantification of the delay incurred before arrival at hospital is of 
prime importance. Knowledge of first aid care received in this period 
is also necessary.  
  Also, as 52.6 % of suicidal poisoning deaths occurred in the 
hospital(33), details about the clinical signs and symptoms, laboratory 
profile and response to therapy, as well as further hospital stay, 
complications and mortality, are necessary.  Detailed case specific 
information on specific poisons ingested and treatment provided, and 
the impact of treatment choices, is desirable. Predictors of mortality 
or prolonged hospitalization also need to be derived. 
In this respect, certain groups of poisons, namely 
Organophosphorous pesticides and plant poisons, have been 
relatively well described in medical literature.  However, there is a 
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realtive paucity of information describing other poison groups, 
especially the non-organophosphorous insecticides, pharmaceuticals, 
corrosives and other chemicals. No prospective data on any of the 
same is available in Indian literature. 
Hence, this study was undertaken with the goal of focusing on 
the profile of the above poison groups, with a descriptive approach, in 
a prospective, hospital based scenario. 
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Methodology 
Site and Duration 
 This study was performed in Christian Medical College 
Hospital (C.M.C.H.), Vellore, a tertiary care referral hospital in 
Vellore, South India, which sees a daily turnover of around 5,860 and 
1,885 outpatients and inpatients respectively.(127) The number of 
poisonings presenting annually to the Emergency department at 
C.M.C.H. is approximately seven hundred. 
 This study was carried out prospectively from January to June 
2010. Patients were seen in the Accident and Emergency 
department, as well as in the medical wards, Gastroenterology ward, 
medical high dependency and intensive care units. 
Study approval 
  The study was cleared by the institutional review board on 
December 16th, 2009 –IRB Min. No 7029. 
Method 
 The investigating physician personally assessed all patients 
included in the study upon inclusion. History was taken from the 
patient, or immediate relative/ witness, if the patient was in altered 
sensorium.  Vital parameters were recorded as documented in the 
triage notes when the patient arrived.  A pre-designed questionnaire 
was used for the standard questions, but additional notes were made 
of clinical findings as encountered (ANNEXURE 3). The patients 
recorded their own GHQ (General Health Questionnaire) 12 scores, 
but a narrator was used for illiterate patients. Death, discharge and 
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additional complication data was obtained from the records of the 
treating physician. Psychiatric diagnosis and advice was taken from 
the records of the treating psychiatrist.   
Informed consent was obtained in Tamil and English before 
study inclusion. 
Inclusion Criteria 
All patients presenting within four days of poison ingestion to 
the Emergency Department of C.M.C.H.  
Exclusion Criteria 
All patients with history of ingestion of Organophosphorous 
poisons (defined as) 
–Identified OP compound 
–Unknown ingested/inhaled poison with clinical profile of OP 
poison, and low butyrl cholinesterase levels (<3000) (128). 
–All patients with history of ingestion of plant components, in 
whatever form. 
Predicted Sample Size 
  Pilot study data (courtesy Toxicology Study Group, CMC 
Vellore) 
As per Aug-Oct 2009, there were 78 cases fulfilling the above criteria.  
Therefore, expected sample size is- 156 cases in 6 months. 
Other studies of similar nature had similar sample sizes. (86-88) 
Data processing and Analysis 
 Third party software applications were used for electronic data 
entry and analysis (OpenClinca (www.OpenClinica.org), and 
    54 
 
Microsoft Excel and SPSS version 16 respectively). Symptoms, signs 
and complications were compiled into a list including all reported 
findings, and subsequently encoded, ensuring minimal loss of 
information.  
 Statistical assistance was obtained from the Department of 
Biostatistics, C.M.C.H. Initial descriptive analysis was performed on 
the entire sample. Categorical variables  were represented with 
frequencies and percentages, while continuous variables were 
displayed as mean/ standard deviations. Subsequently, an inter-
group comparison of parameters was performed between pesticides, 
prescription drugs and corrosive/chemicals, using Pearson’s Chi-
square and One-way Analysis of Variance for categorical and 
continuous variables respectively. Finally, a binary logistic regression 
analysis was performed to determine significant predictors of hospital 
admission. 

























Flow chart  







97 OP  poisonings 235 Non plant, Non 
OP poisons
32 Plant poisonings
126 lost due to
Lack of consent,  or death, or
discharge prior to inclusion
109 patients 
consented 
All Admissions   91%













DAMA= Discharge against medical advice; 
 OP= Organophosphorous poisons; ; 
 ICU = intensive care unit. 
 





































































































Table 1.  
Results of analysis, all patients  
(Categorical variables represented as percentage; Continuous variables as mean, standard deviation (S.D.), minimum and 




 no % mean SD min Max 
Age 109 
 
26.63 8.136 15 63 
Sex 
     
 
male 46 42.2 
   
 female 63 57.8 
   
 Education 
     
 
mid-school and below 29 26.6 
   
 high school 45 41.3 
   
 graduate 22 20.2 
   
 Occupation 
     
 housewife 39 35.8 
   
 Farmer/Labourer 17 15.6 
   
 
student 11 10.1 
   
 
others 35 32.1 
   
 Urban or Rural 
   
 
rural 61 55.9 
   
 
urban 34 31.2 
   
 Multiple poisons 
     
 yes 17 15.6 
   
 
no 92 84.4 
   
 Site of ingestion 
     
 
other 18 16.5 
   
 home 90 82.6 
   
 Source of poison 
     
 purchased from store 25 22.9 
   
 domestically available 81 74.3 
   
 Co-ingested substance 
     
 None 27 24.8 
   
 Alcohol 11 10.1 
   
 
water/others 58 53.2 
   
 Reason for poisoning 
     
 inter-personal conflict 53 48.6 
   
 Unemployment/Job/Study pressure 16 14.7 
   
 Mental or Physical illness 17 15.6 
   
 
others 17 15.6 
   
 Accidental ingestion 5 4.6 
  
 Impulsive or premeditated 
     
 impulsive 80 73.4 
   
 pre-meditated 14 12.9 
   
 Delay (hrs) 109 
 
6.1 9.3 .50 84.83 
Gastric lavage elsewhere 
    
 
no 19 17.4 
   
 yes 32 29.4 
   
 First aid at outside hospital 
    
 
no 57 52.3 
   
 yes 45 41.3 
   
 Pulse 105 
 
114.3 20.5 80 170 
Diastolic BP 105 
 
78.6 16.5 50 140 
Systolic BP 105 
 
118.0 17.8 90 160 
Respiratory Rate 102 
 
24.2 4.2 15 48 
O2 Saturation 105 
 
96.4 4.1 78 100 
Temperature 96 
 
98.1 0.7 97 104 
 
Overall, young persons and females were predominant. Most persons had a high-school education. Housewives 
formed the single largest population group. Most poisons were ingested at home and were available domestically. 
Inter-personal conflicts were the most common precipitant reasons cited. The average time delay was 6.1 hrs (5.06 
hrs when outliers (n=2, >24hrs) removed). Only a minority received first aid and stomach wash prior to presentation. 
Table 1.  
Results of analysis, all patients  
(Categorical variables represented as percentage; Continuous variables as mean, standard deviation (S.D.), minimum and 




 no % mean SD min Max 
GRBS 93 
 
125.4 40.6 76 264 
Pupil size 96 
 
3.9 1.0 1 6 
ECG rate 65 
 
96.3 23.5 50 150 
PR interval 67 
 
142.5 25.8 88 198 
QTc interval 67 
 
427.1 36.1 322 560 
Gastric lavage in CMCH 
      
no 54 49.5 
    yes 55 50.5 
    Admitted 
      
no 76 69.7 
    yes 33 30.3 
    In-patient days 109 
 
1.8 5.5 0 41 
Intubated 
      
no 97 89.0 
    yes 12 11.0 
    Intensive care required 
      
no 96 88.1 
    yes 13 11.9 
    
vSodium 106 
 
139.2 3.8 132 156 
vPotassium 106 
 
3.6 0.5 2.1 5.5 
vHCO3 105 
 
19.8 3.3 8 26 
vCalcium 7 
 
7.343* 2.2560 4.1 9.6 
vPhosporous 6 
 
3.0 2.0 1 7 
Total Bilirubin 37 
 
1.0 1.7 .4 8.4 
direct Bilirubin 38 
 
0.3 0.6 .1 3.8 
Total Protein 37 
 
7.9 0.8 5.5 9.9 
Albumin 37 
 
4.5 0.4 3.1 5.8 
SGOT 38 
 
185.0 593.0 12 3259 
SGPT 38 
 
81.2 255.6 5 1460 
Alkaline Phosphatase 37 
 
70.5 30.3 12 168 
Creatinine 102 
 
1.0 0.2 .5 1.8 
Urea 17 
 
23.4 7.4 15 43 
Any complication? 
      
no 47 43.1 
    yes 47 43.1 
    Mortality 2 1.8 
    GHQ >= 3 
      
no 28 25.7 
    yes 39 35.8 
    Psychiatric illness 
      
nil 12 11.0 
    Depression/ BPAD/ Dysthymia 12 11.0 
    Adjustment disorder 15 13.8 
    
other disorder 9 8.3 
    History of substance abuse 
     
no 81 74.3 
    yes 12 11.0 
    Need for further psychiatric care 
     
no 8 7.3 
    yes 42 38.5 
    Duration of IP stay 
  
.69 1.405 0 5 
 
One third of patients seen in casualty were subsequently admitted. Only half the patients saw a psychiatrist prior to 
leaving the hospital. Adjustment disorder was the commonest psychiatric diagnosis.  
Table 2a.  
Results of analysis, patients who took only one poison type (n=92). 
 
(Categorical variables represented as percentage, with Chi-square test for significance; Continuous variables represented as mean, standard deviation (S.D.) and one-way ANOVA level of 
significance. Percentage represents all respondents of total queried,; missing values not displayed.) 
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 PESTICIDE PRESCRIPTION 
DRUGS 
CORROSIVES AND OTHER 
CHEMICALS 
    
 
n % mean S.D. n % mean S.D. n % mean S.D. 
2 sided 
Significance. Pearson Chi-Square Value F df 
Age 28 25.2 5.3 42 27.8 8.3 22 26.2 10.5 .422 
 
.872 2 
Sex                       
    
  
  
    
  
  .010 9.305 2 
male 20 18.3% 
 
20 18.3%   6 5.5%     
  
  
female 11 10.1% 
 
36 33.0%   16 14.7%     
  
  
Education              






  .035 10.312 4 
mid-school and 
below 15 15.6% 
 
11 11.5%   3 3.1%     
  
  
high school 11 11.5% 
 
24 25.0%   10 10.4%     
  
  
graduate 3 3.1% 
 










  .008 17.447 6 
housewife 6 5.9% 
 
25 24.5%   8 7.8%     
  
  
Farmer/Labourer 9 8.8% 
 
5 4.9%   3 2.9%     
  
  
student 2 2.0% 
 
3 2.9%   6 5.9% 
 others 12 11.8% 
 
18 17.6%   5 4.9%     
  
  
Rural or Urban 
            
.022 7.664  2 
Rural 22 23.2% 25 26.3% 14 14.7% 
   Urban 6 6.3% 24 25.3% 4 4.2% 
   Site of ingestion  






 .004 11.085 2 
other 11 10.2% 
 
5 4.6%   2 1.9%     
  
  
home 20 18.5% 
 
50 46.3%   20 18.5%     
  
  
Males preferred pesticide, where as pharmaceuticals and corrosives were predominantly taken by females. Education was poorest amongst 
pesticide ingestors.  Farmers and labourers predominated among the pesticide group, where as housewives predominated in the other groups. 
Students were a significant group among corrosive ingestors. Pharmaceuticals were more common among the urban, and pesticides tended to 
occur more in the rural. While all poisons were ingested most commonly at home, pesticide poisoning occurred often outside the home as well. 
Table 2b.  
Results of analysis, patients who took only one poison type (n=92). 
 
(Categorical variables represented as percentage, with Chi-square test for significance; Continuous variables represented as mean, standard deviation (S.D.) and one-way ANOVA level of 
significance. Percentage represents all respondents of total queried,; missing values not displayed.) 
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 PESTICIDE PRESCRIPTION DRUGS CORROSIVES AND OTHER 
CHEMICALS 
    
 
n % mean S.D. n % mean S.D. n % mean S.D. 
2 sided 
Significance. Pearson Chi-Square Value F Df 
Source of poison 






  <.001 16.412 2 
purchased from store 15 14.2% 
 
8 7.5%   2 1.9%     
  
  
domestically available 15 14.2% 
 










  <.001 49.587 4 
None 8 8.3% 
 
4 4.2%   15 15.6%     
  
  
Alcohol 8 8.3% 
 
3 3.1%   0 0.0%     
  
  
water/others 10 10.4% 
 
44 45.8%   4 4.2%     
  
  
Reason for ingestion 






  .009 17.170 6 
inter-personal conflict 13 12.6% 
 
27 26.2%   13 12.6%     
  
  
Unemployment/Job/Study pressure 8 7.8% 
 
5 4.9%   3 2.9%     
  
  
Mental or Physical illness 1 1.0% 
 
15 14.6%   1 1.0%     
  
  
others 7 6.8% 
 
5 4.9%   5 4.9%     
  
  
Impulsive or premeditated 
     
.796 0.455 2 
impulsive 24 25.5% 42 44.7% 
 
14 14.9% 
   premeditated 3 3.2% 8 8.5% 
 
3 3.2% 
   Gastric lavage outside 






  .318 2.292 2 
no 10 19.6% 
 
6 11.8%   3 5.9%     
  
  
yes 10 19.6% 
 
15 29.4%   7 13.7%     
  
  
Pesticides were sourced equally often from home and purchase stores. However, the pharmaceuticals and corrosives consumed were 
domestically available. Alcohol co-ingestion was mostly noted among pesticide poisonings, while corrosives were ingested directly.  Vocational 
stressors were relatively more common among pesticide ingestors, while persons with chronic mental or physical illnesses took pharmaceutical 
poisons. Pharmaceutical overdoses commonly occurred 
Table 2c.  
Results of analysis, patients who took only one poison type (n=92). 
 
(Categorical variables represented as percentage, with Chi-square test for significance; Continuous variables represented as mean, standard deviation (S.D.) and one-way ANOVA level of 
significance. Percentage represents all respondents of total queried,; missing values not displayed.) 
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 PESTICIDE PRESCRIPTION DRUGS CORROSIVES AND OTHER  
CHEMICALS 
    
 
n % mean S.D. n % Mean S.D. N % mean S.D. 
2 sided 
Significance. Pearson Chi-Square Value F df 
First aid at outside hospital 






  .049 6.014 2 
no 11 10.8% 
 
35 34.3%   11 10.8%     
  
  
yes 18 17.6% 
 
18 17.6%   9 8.8%     
  
  
Delay in presentation(hrs) 28 4.6 3.0 42 6.4 5.4 22 5.7 8.5 .460 
 
.784 2 
Pulse 28 114.3 20.5 40 103.9 23.4 21 93.9 17.8 .005 
 
5.554 2 
Diastolic BP 28 78.6 16.5 39 77.2 12.1 21 74.8 9.3 .603 
 
.509 2 
Systolic BP 28 118.0 17.8 40 115.0 17.7 21 114.3 14.3 .697 
 
.362 2 
Respiratory Rate 28 25.5 6.4 40 23.8 3.1 20 23.4 3.5 .201 
 
1.634 2 
O2 Saturation 28 95.6 4.3 41 97.0 3.2 20 95.1 6.3 .230 
 
1.494 2 
Temperature 27 98.3 0.7 36 98.2 1.0 18 98.1 0.3 .787 
 
.241 2 
GRBS 24 122.1 38.6 35 125.7 35.1 19 137.6 57.7 .472 
 
.759 2 
Pupil Size 27 4.0 1.2 37 4.0 1.1 19 4.0 0.9 .996 
 
.004 2 
ECG rate 16 96.6 21.4 24 99.9 24.8 13 101.7 25.8 .844 
 
.170 2 
PR interval 16 134.8 20.3 26 142.4 24.5 13 139.7 29.2 .619 
 
.484 2 
QTc interval 16 420.9 23.0 26 424.1 35.9 13 443.4 39.0 .159 
 
1.905 2 
vSodium 28 140.7 4.2 40 138.8 3.8 21 138.5 2.9 .065 
 
2.816 2 
vPotassium 28 3.5 0.6 40 3.6 0.4 21 3.7 0.6 .424 
 
.867 2 
vHCO3 28 19.2 4.1 40 20.3 2.7 21 19.0 3.4 .271 
 
1.327 2 
vCalcium 1 8.9 . 4 7.7 2.4 2 5.9 2.5 .593 
 
.598 2 




Tachycardia was most significantly present amongst pesticide ingestors. There was no significant difference among the three categories of 
poisons with respect to the other vital signs and baseline investigations.
Table 2d.  
Results of analysis, patients who took only one poison type (n=92). 
 
(Categorical variables represented as percentage, with Chi-square test for significance; Continuous variables represented as mean, standard deviation (S.D.) and one-way ANOVA level of 
significance. Percentage represents all respondents of total queried,; missing values not displayed.) 
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 PESTICIDE PRESCRIPTION DRUGS CORROSIVES AND OTHER  
CHEMICALS 
    
 
n % Mean S.D. n % mean S.D. n % mean S.D. 
2 sided 
significance. Pearson Chi-Square Value F Df 
Total Bilirubin 7 1.5 2.4 15 0.7 0.4 7 0.7 0.2 .281 
 
1.332 2 
direct Bilirubin 7 0.2 0.0 16 0.2 0.1 7 0.3 0.2 .402 
 
.942 2 





4.7 0.6 15 
 
4.6 0.3 7 
 





286.3 658.3 16 
 
19.9 5.8 7 
 





220.6 546.6 16 
 
13.9 7.7 7 
 
107.9 187.8 .256 
 
1.435 2 
Alkaline Phosphatase 7 
 
80.9 29.4 15 
 
62.8 26.9 7 
 
75.6 25.8 .310 
 
1.225 2 
Creatinine 27 1.0 0.2 39 0.9 0.1 21 1.0 0.2 .009 
 
5.024 2 
Urea 6 27.0 10.2 4 22.8 5.7 5 20.0 2.9 .321 
 
1.251 2 
Gastric lavage in CMCH 






  .001 15.006 2 
no 13 11.9% 
 
22 20.2%   19 17.4%     
  
  
yes 18 16.5% 
 










  .067 5.400 2 
no 22 20.2% 
 
43 39.4%   11 10.1%     
  
  
yes 9 8.3% 
 










  .482 1.459 2 
no 28 25.7% 
 
51 46.8%   18 16.5%     
  
  
yes 3 2.8% 
 
5 4.6%   4 3.7%     
  
  
Intensive care required 






  .278 2.561 2 
no 26 23.9% 
 
52 47.7%   18 16.5%     
  
  
yes 5 4.6% 
 




Pesticide ingestors were found to have higher creatinine values at admission (possibly confounded by larger numbers of males). Gastric lavage 
was withheld to corrosive and chemical ingestors in this hospital.
Table 2e.  
Results of analysis, patients who took only one poison type (n=92). 
 
(Categorical variables represented as percentage, with Chi-square test for significance; Continuous variables represented as mean, standard deviation (S.D.) and one-way ANOVA level of 




PESTICIDE PRESCRIPTION DRUGS CORROSIVES AND OTHER  
CHEMICALS 
 
   
 
n % mean S.D. n % mean S.D. n % mean S.D. 
2 sided 
Significance. Pearson Chi-Square Value F df 
Any complication 






  .021 7.705 2 
no 15 16.0% 
 
27 28.7%   5 5.3%     
  
  
yes 13 13.8% 
 










  .090 4.817 2 
no 26 27.7% 
 
45 47.9%   21 22.3%     
  
  
yes 2 2.1% 
 
0 0.0%   0 0.0%     
  
  
In-patient days 28 0.8 1.5 42 0.7 1.4 22 6.2 11.0 <.001 
 
8.361 2 
GHQ >=3 .901 .195 2 
no 8 11.9% 15 22.4% 5 7.5% 
yes 13 19.4% 20 29.9% 6 9.0% 
Psychiatric illness 
        
.097 10.743 6 
nil 3 6.3% 7 14.6%   2 4.2%     
  
  
Depression/ BPAD/ Dysthymia 3 6.3% 9 18.8%   0 0.0%     
  
  
Adjustment disorder 9 18.8% 4 8.3%   2 4.2%     
  
  
other disorder 1 2.1% 6 12.5%   2 4.2%     
  
  
History of substance abuse 
        
.129 4.097 2 
no 20 21.5% 43 46.2%   18 19.4%     
  
  
yes 6 6.5% 3 3.2%   3 3.2%     
  
  
Need for further psychiatric 
care 
        
.728 .635 2 
no 2 4.0% 4 8.0%   2 4.0%     
  
  
yes 14 28.0%     22 44.0%     6 12.0%           
Complication rates were significantly higher among corrosive ingestors than other groups. In patient stay was maximal among the corrosive 
ingestion group.  





A stepwise logistic regression of all parameters was 
performed to determine predictors of admission to 
the hospital.  
In the univariate analysis, 4 characteristics were found 
to be of significance- Systolic Blood Pressure, O2 
saturation, GRBS and Respiratory rate;  
In the final analysis, Systolic Blood Pressure, O2 
saturation, GRBS were found to be significant 
predictors of admission  
 
Odds Ratio Estimates 
Effect Point Estimate 95% Wald Confidence limits 
Systolic Blood Pressure 1.056 1.010 1.105 
O2Saturation 0.794 0.674 0.936 


















































Although this is a hospital based study, the demographic 
profile of patients resembles that of recent community based studies, 
in terms of youth predominance. Also, female predominance is noted 
among the young as in other studies, (6-9) suggesting that access to 
healthcare was not denied to any demographic group. However, elder 
males were not seen commonly among the group poisons studied- 
possibly due to exclusion of organophosphorous pesticides. 
  The majority of morbidity and mortality due to poisonings affect 
the young.  Similar findings were reported by the community based 
studies. This may reflect the population age profile, but it is more 
likely that young people take more poison due to other factors. 
Women were the predominant sex; this too concurred with the 
community studies.  Most persons in this study had completed 
education up to high school, and the predominant occupation was 
being a housewife- blue collar workers were a minority. This may be 
because most farmers and labourers, who take organophosphates, 
were excluded in this study.  
The fact that most poisonings occurred impulsively, in the 
home, with poisons that are available domestically, suggests that the 
majority of acts of poisoning are acutely planned and executed with 
the most readily available agent. Accidental poisonings comprised 
only a very small number, and were mainly related to errors in 
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medical drug prescription, or unsafe storage of poisons in 
food/beverage containers. 
The most common reason cited for poison ingestion was a 
stressor in the form of a relational conflict, or vocation-related 
stressor, mainly unemployment, dissatisfaction with job or poor 
academic performances. Psychiatric or physical illness as a whole 
was a minor contributing factor to direct attributable reason for 
poisoning. This supports recent reports from India, which describe 
that psycho-social distress, rather than psychiatric disease, is the 
main reason for poisoning.(9) This is unlike the western scenario, 
where psychiatric disease predominates. 
The duration of time elapsed between poisoning and 
presentation has important implications as most persons are alive for 
the first four hours after poison ingestion(33). Therefore, this delay in 
accessing healthcare may be a cause for high mortality. This delay 
has never been described in literature from India as far as we are 
aware.  
 
Inferences derived from comparing between the different groups 
of poisons 
The differences in choice of poison between the sexes 
probably reflects the proximity of the particular agent chosen, with 
males having easier access to and availability of pesticides, and 
females having more access to the other two groups, in view of their 
respective professions.  
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A pattern therefore begins to emerge, with two main poles- at 
one extreme, the less educated male farmer(or labourer) who in 
response to severe psycho-socio-economic stressors, consumes 
pesticide in an attempted act of suicide; and at the other extreme 
pole, that of the better educated female housewife or student, who in 
response to a stressor, preferentially poisons herself with the 
immediately  accessible poison- usually a drug or sometimes that of a 
corrosive agent. The reason that corrosive poison (usually toilet 
cleaning acid) was taken more often by students/housewives as 
compared to farmers may reflect better housing conditions and 
attached toilets among the former, where the acid is stored. 
Of the three groups, alcohol co-ingestion was present mainly 
among the pesticides. This may correlate with the increased 
prevalence of males in this group. 
Among the three groups, the highest proportion of adjustment 
disorder among the farmer/labourers is possibly a marker of severe 
psycho-social stress being most prevalent among this group. This 
may be compounded by their lower education level, as described 
above. 
The reason that pesticides more often than the other two 
groups, were initially treated at an outside hospital and had higher 
rates of gastric lavage, may be in part due to the fact that many of 
these poisonings occurred away from home- thereby causing the 
patients to be taken initially to the nearest available medical facility by 
a bystander. 
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Previous reports had suggested a link between mental illness, 
chronic pain and prescription drug over dosages, especially narcotics 
(129). In this study, it was clear that persons with the above preferred 
drugs.  
It is a matter of concern to note that despite there being clear 
evidence to avoid gastric lavage in cases of corrosive poisoning, it 
was still noticeably prevalent. Therefore, better education of primary 
care givers on this matter is necessary. The few cases of lavage 
administered to corrosives in our hospital were accidental, due to the 
clinical history and picture being non-lucid at presentation.  
As a significant proportion of pesticides were purchased 
immediately before their consumption, the potential benefits of stricter 
regulation and restriction on sale of pesticides need to be seriously 
considered. 
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Conclusion 
From this study, it appears that the overall demography of 
poisonings matches that of other reports from India, with youth 
predominance. Also, the vast majority of poisoning were reported as 
impulsive, with the most common reasons being inter-personal 
conflicts and social/economic stressors; psychiatric morbidity 
accounted only for a small percentage of the same- confirming the 
findings of other previous authors (47). This is in contrast to western 
data, where poisoning usually occurs amongst the middle aged, often 
resulting from psychiatric disease (4). Psychotropic drugs formed the 
single largest pharmaceutical group, followed by acetaminophen. 
Among the non-organophosphorous poisons, pyrethroids were 
common, while inorganic “cleaning acids” were the most common 
corrosives. Around one-third of all patients required further ward 
admission while one tenth required ICU care.  
There were statistically significant differences between the 
three groups (non-organophosphorous pesticides, prescription drugs 
and corrosives/ chemicals) with respect to sex, literacy, occupation, 
rural-urban distribution, pattern of ingestion  (i.e. - ingestion site, 
poison source, co-ingestant, reason for ingestion, first aid utilisation), 
complication rates and duration of ward stay. It therefore appears that 
different classes of people reach for different poison agents, when in 
distress. This has important implications for preventive strategies. A 
specific approach is required to ensure that limitation of access to 
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poisons, as well as psychological education, is appropriate to the 
individual concerned.  Also, the prognosis varies widely based on the 
exact nature of the ingested compound. 
There was a significant delay in presentation to this hospital 
(mean – 6 hours), with paucity of appropriate first aid measures, and 
occasional harmful treatment outside (such as administration of 
gastric lavage in corrosive poisonings), stressing the need for better 
training and equipping of health services. Previous authors have 
shown that most persons are alive for the first four hours following 
poison ingestion. Therefore, this information has important 
implications. 
The psychiatric profile available from the limited number of 
patients shows that adjustment disorders predominate, suggestive of 
acute psychological stress rather than disease. GHQ (General Health 
Questionnaire) 12 scores were also positive in the majority of persons 
questioned. 
 On the whole, measures to prevent poisoning require a holistic 
approach- with minimizing access to harmful substances through 
safer storage and distribution methods, as well as rationally limiting 
the availability of toxic agents to the minimum necessary, especially 
in the domestic environment, where most cases of poisonings are 
likely to occur.  This requires a public health approach, with 
community education and awareness building toward prevention, 
equipping of health services to deal with the situation and strict 
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legislation to curtail distribution of these agents to the lowest required 
level. Implementation of this will certainly lead to an improvement in 
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ANNEXURE 1: DATA TABLES
HospNo Name Age Sex Address Education Occupation multiplepoisons P_Class1 PoisonCode1 P_Class2 PoisonCode2
049179B SARASWATHY 17 2 2/37, BUTHER STREET  PERMUGI  VELLOREhigher secondary unemployed yes DRUG UNKNOWN TAB DRUG .
055619D BASKAR 33 1 155 THOPPU STREET  VANAPADI  RANIPET  VELLORENIL unemployed no DRUG ANTIPSYCHOTIC . .
080438C CHITRA 29 2 26,R.N.PALAYAM  KASPA,VELLORENIL MISSING yes DRUG PARACETAMOL DRUG .
104402B PREMA KUMARI 35 2 SILK MILL  BVELLORE higher secondary CMCemployee yes DRUG ANTI HYPERTENSIVE DRUG .
125871B IRUCHAPPAN 59 1 MUDINAMPATTU  GUDIYATHAM 10th farmer yes DRUG ORAL HYPOGLYCEMIC DRUG OTHER TAB
130886B KARTHIKA 16 2 19, SANJEEV PILLAI STREET  SABARAMEDU, VELLOREhigher secondary student yes INSECTICIDE INSECTICIDE(UNKNOWN) CORROSIVE/CHEMICALHYDROCARBON
154632D KAVITHA 33 2 2/90,I6, DURAI SAMY MUDALI STREET  VIRUPATCHI PURAM  VELLORE  VELLOREgraduate housewife yes DRUG BENZODIAZEPENE DRUG .
284442D SHANTHI 41 2 4/10, RAMANATHAPURAM VILLAGE  KILMUTHUR POST  KATPADI, TAMIL NADU<5th housewife yes DRUG PARACETAMOL DRUG .
301377A REVATHY 28 2 5/1 KANNA STREET  SAIDAPET  VELLOREhigher secondary housewife no DRUG BENZODIAZEPENE . .
305859D JOTHI V 22 2 PILLAYAR KOIL ST  MELVADUNGAKAM, KARASAMANGALAM, VELLORE  TAMIL NADUunknown housewife no DRUG HYPNOTIC(OTHER) . .
329758D DHANAKOTTI S 33 2 DHARANAMPET, GUDIYATTAM, VELLORE  ELECTRICIANunknown labourer no CORROSIVE/CHEMICAL INORGANIC ACID . .
369765A SARAVANAN 28 1 9/1, KALAS RAM SINGH STREET,  VELLOREunknown MISSING no DRUG HYPNOTIC(OTHER) . .
378016D KAVITHA S 25 2 VADUGATHIPPATTI  MADHANOOR VIA  VELLORE  TAMIL NADU  9994083101unknown housewife no CORROSIVE/CHEMICAL INORGANIC ACID . .
611155D JEYAKODI 19 2 MARIAMMAN KOIL STREET  SITHARAN PETTAI  K V KUPPAM  VELLORE<5th housewife no INSECTICIDE INSECTICIDE(UNKNOWN) . .
613415D LAKSHMI KUMAR 24 1 MALLERE, KALLUPALL PO  GANGA  CHITTOOR APunknown farmer no NON INGESTED INSECTICIDE(UNKNOWN) . .
613446d SURESH KUMAR 32 1 NAGALUNG ISHWAR STREET  PERIYAL ALLAPURAM  VELLOREunknown labourer no INSECTICIDE PYRETHROID . .
616309D SANGEETHA M 26 2 3/52, CHENDRAMPALLI  KILIMUTHUR  KATPADI  VELLORE10th housewife no CORROSIVE/CHEMICAL INORGANIC ACID . .
616311D SHARMILLA BANU 39 2 28/204, TELEPHONE COLONY,  CHITTOOR  ANDHRA PRADESHdiploma others yes DRUG PARACETAMOL DRUG ANTIHISTAMINE
616312D BABY RANI 32 2 3-248, HOUSING BOARD,'OPERAPALLI  CHITTOORdiploma housewife no DRUG OTHER TAB . .
616313D VINO ANAND 24 1 47, SEKIZHER STREET, E.B NAGAR, ARNI, THIRUVANAMALAIgraduate MISSING no INSECTICIDE INSECTICIDE(UNKNOWN) . .
616320D PRAGADEESWARAN E. 28 1 8, MARATHODI SHANN ARASAMPET,  VELLOREunknown others no CORROSIVE/CHEMICAL OTHER CHEMICAL . .
620135D REDYAPA 21 1 PALAMNER  CHITTOOR  ANDHRA PRADESHunknown labourer no INSECTICIDE PYRETHROID . .
620140D DINISHA 19 2 VELKUR  G D NELLOREMANDAL  CHITTOOR  ANDHRA PRADESHgraduate student no CORROSIVE/CHEMICAL INORGANIC ACID . .
620141D SHAKILA 27 2 KODOKHIAL VILLAGE,  VELLORE  TAMIL NADUNIL housewife no DRUG ANTIHISTAMINE . .
620160D RAGHAV KANSAL 18 1 VIT VELLORE higher secondary student no DRUG PARACETAMOL . .
620359D PERUMAL T 29 1 MARIAMMAN KOIL ST,  PAPANAPATTU  VILLUPURAMhigher secondary labourer no CORROSIVE/CHEMICAL AMMONIUM DERIVATIVE . .
620391d MANJU JEYAKUMAR 25 2 896, second mainroad, rajaji nagar, karnataa.u known MISSING no DRUG ANTIHISTAMINE . .
620549D LEELAVATHI R 24 2 S.V. COLLEGE  THIRUPATHUR postgraduate student no CORROSIVE/CHEMICAL INORGANIC ACID . .
620600D SUBBALAKSHMI 28 2 NO 25 ASHOK NAGAR, GUDIYATTAM VELLOREunknown housewife no DRUG UNKNOWN TAB . .
625165D HARI 26 1 KASB, VELLORE TN <5th labourer no CORROSIVE/CHEMICAL INORGANIC ACID . .
625455D THIRUVUNAKARASU 27 1 KRISHNA VASAL  SANTHAVAPURAM  THIRVUNAMALAI10th farmer no INSECTICIDE PYRETHROID . .
625505D KARTHIKEYAN 24 1 24, TANNERY GOGOWN STREET, OLD TOWN, VELLOREpostgraduate MISSING no DRUG BENZODIAZEPENE . .
625555D MANJU SARANYA 20 2 NO.148 ROAD STREET  THALANUR SATHIRAM  ARCOT VELLORE10th housewife no INSECTICIDE PYRETHROID . .
628761D JAYAVELU K 37 1 RAMACHANDRAPURAM  KATTAKANNUR POST OFFICE  ARNI TALUK  THIRUVANAMALAIhigher secondary others no CORROSIVE/CHEMICAL OTHER CHEMICAL . .
630010D BASKARAN 23 1 109,VANNIYAR ST  SRIKALIKAPURAM  ERUMBI  VELLOREhigher secondary unemployed no DRUG ANTIHISTAMINE . .
630016D RAVI 27 1 KAMMATHIMAM PALLI VILLAGE  PAKALA POST  CHITTOORdiploma unemployed no DRUG ANTIHISTAMINE . .
638113D VASU 28 1 MORDHANA PALLI  KUKALAPALLI  VEDAMARY MANDALAM  CHITTOOR7th mason no RODENTICIDE UNKNOWN RODENTICIDE . .
638257D KUPPAN 27 1 KULATHUR -  THIMMAMPETTAI  KANNAMANGALAM-VIA  VELLORE TAMIL NADU10th driver no INSECTICIDE PYRETHROID . .
638596D SASIREKHA 22 2 SANNATHI STREET  KAARAPATTU  CHENGAM  THIRUVANAMALAI10th housewife no DRUG ANTIPSYCHOTIC . .
640426D MUNIYAMMAL 25 2 PANNAI VEEDU  GANDHI NAGAR  PERANAMALLUR, VANDAVASI  THIRUVANNAMALAINIL housewife no INSECTICIDE FERTILISER . .
641390D LAKSHMI D 38 1 10 RAJA DESHINGH NAGAR  GINGEE  T V MALAI VIA VILLIPURAM  TAMIL NADU10th housewife no DRUG BENZODIAZEPENE . .
642729D RAMU V 30 1 99,  AMBEDKAR ST  THUTHIPET VILL8th others no INSECTICIDE PYRETHROID . .
645820D ATHIYA SHAHEEN 22 2 9/2 FAKIR SAHEB STREET,  SAIDAPET,   VELLORE8th housewife no INSECTICIDE INSECTICIDE(UNKNOWN) . .
646798D SARAVANAN 29 1 CHERLOPALLI  CHITTOOR  ANDHRA PRADESH10th labourer no DRUG PHENOTHIAZIENE . .
648354D MANIMARAN G 24 1 33/13 NEW ST.  AMMOOR  WALAJAH  VELLORE10th others no INSECTICIDE PYRETHROID . .
648363D PRAMEELA 63 2 4-1774, B-BLOCK  DURGA NAGAR COLONY  GREAMSPET  CHITTOOR10th housewife no CORROSIVE/CHEMICAL INORGANIC ACID . .
648376D VENKATESAN 21 1 NETHAJI NAGAR  VANIYAMBADI  VANIYAMBADI  VELLORE  TAMIL NADUNIL farmer no INSECTICIDE CARBAMATE . .
651203D KAVITHA 19 2 NO.7/4 SUBRAMANI  STREET  THORAPADI  VELLORE  VELLORE  9789872800higher secondary unemployed no CORROSIVE/CHEMICAL HYDROCARBON . .
651387D JAYASHREE 27 2 NO-12, 3 RD CROSS VADIVEL NAGAR  SANKARANPALAYAM  VELLORE  VELLOREpostgraduate unemployed yes DRUG PARACETAMOL DRUG ANALGESIC(OTHER)
651488D JOTHI LAKSHMI K 26 2 6-77 VINAYAGAPURAM  PENUMOOR VILLAGE  PENUMOOR POST   CHITTOOR  ANDHRA PRADESHpostgraduate teacher no D UG ANTI-EPILEPTIC . .
651530D GAYATHRI V 23 1 221 RAMASWAMY PILLAI STREET  KAMALAKSHIPURAM  OTTERI  VELLORE  TAMIL NADU  9994465741higher secondary housewife no DRUG ORAL HYPOGLYCEMIC . .
658126D LALITHA J 27 2 5 MANAKULA VINAYAGAR STREET  NEAR POST OFFICE  RAMANA NAGAR  THIRUVANNAMALAI  TAMIL NADUpostgraduate housewife no CORROSIVE/CHEMICAL PHENOL/ORGANIC ACID . .
661067D MANIMEGALA 16 2 26/195 P.H. COLONY  ERUVARAM  CHITTOOR  ANDRA PRADESHhigher secondary student no CORROSIVE/CHEMICAL VASMOL DYE . .
661188D AMUDHA 20 2 C M KANDIGAI  SRI KAVARAJIPURAM  PUTTUR TK  CHITTOOR6th housewife no CORROSIVE/CHEMICAL AMMONIUM DERIVATIVE . .
668971D ARUN KUMAR 20 1 SILERI  GANGANELLORE,  ANAICUT  VELLORE  TAMIL NADU9th others no INSECTICIDE ENDOSULFAN . .
669787D KANNI DAS 23 1 16 WRITER ANNASWAMY STREET  ARASAMARAPETTAI  VELLOREgraduate others yes RODENTICIDE UNKNOWN RODENTICIDE INSECTICIDE INSECTICIDE(UNKNOWN)
670427D SENTHIL KUMAR 30 1 57 AVALKAR STREET  KOSALPET  VELLORE  VELLOREpostgraduate unemployed yes DRUG NEWER ANTIDEPRESSANT DRUG ANTI HYPERTENSIVE





























































P_Class3 PoisonCode3 P_Class4 PoisonCode4 P_Class5 PoisonCode5Amount1 Amount2 Amount3 Amount4 Amount5 Dose1 Dose2 Dose3 Dose4 Dose5 Units Placeofingestion
. . . . . . 6 4 . . . 0 100 0 0 0 . home
. . . . . . 88 . . . . 0 0 0 0 0 . home
. . . . . . 4 4 . . . 2,000 2,500 0 0 0 . home
DRUG OPIOID . . . . 20 10 9 . . 100 100 0 0 0 . home
DRUG OTHER TAB DRUG ANTI HYPERTENSIVE. . 30 20 20 20 . 30,000 1,500 200 1,500 0 . home
. . . . . . 20 . . . . 0 0 0 0 0 . home
. . . . . . 20 37 . . . 100 18,500 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 20 . . . . 5 0 0 0 0 . home
. . . . . . 12 . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . home
. . . . . . 60 . . . . 1,800 0 0 0 0 . home
. . . . . . 20 . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 250 0 0 0 0 . home
. . . . . . 50 . . . . 475 0 0 0 0 . home
DRUG BENZODIAZEPENE. . . . 4 9 16 . . 2,600 90 4 0 0 . other
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . other
. . . . . . 100 . . . . 0 0 0 0 0 . home
. . . . . . 250 . . . . 2,500 0 0 0 0 . other
. . . . . . 1 . . . . 0 0 0 0 0 . home
. . . . . . 25 . . . . 625 0 0 0 0 . home
. . . . . . 15 . . . . 7,500 0 0 0 0 . other
. . . . . . 15 . . . . 0 0 0 0 0 . other
. . . . . . 20 . . . . 200 0 0 0 0 . other
. . . . . . 50 . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 300 . . . . 0 0 0 0 0 . other
. . . . . . 100 . . . . 0 0 0 0 0 . home
. . . . . . 15 . . . . 4 0 0 0 0 . home
. . . . . . 35 . . . . 56 0 0 0 0 . home
. . . . . . 250 . . . . 0 0 0 0 0 . home
. . . . . . 15 . . . . 375 0 0 0 0 . other
. . . . . . 30 . . . . 1,500 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . other
. . . . . . 100 . . . . 1,000 0 0 0 0 . other
. . . . . . 20 . . . . 2,000 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . home
. . . . . . 12 . . . . 3 0 0 0 0 . home
. . . . . . 10 . . . . 100 0 0 0 0 . other
. . . . . . 50 . . . . 0 0 0 0 0 . home
. . . . . . 8 . . . . 600 0 0 0 0 . home
. . . . . . 45 . . . . 0 0 0 0 0 . other
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . 150 . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . home
DRUG OTHER TAB DRUG . DRUG . 9 . . . . 0 0 0 0 0 . home
. . . . . . 9 . . . . 850 0 0 0 0 . home
. . . . . . 20 . . . . 10,000 0 0 0 0 . home
. . . . . . 50 . . . . 0 0 0 0 0 . home
. . . . . . 5 . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 3,500 0 0 0 0 . home
DRUG ANTI-EPILEPTICDRUG BENZODIAZEPENE . . 15 20 50 . . 0 2,000 250 0 0 . home
DRUG UNKNOWN TAB . . . . 10 . 40 . . 0 0 0 0 0 . other
. . . . . . 4 . . . . 0 0 0 0 0 . home






























































Sourceofingestion Coingestant Reasonforpoisoning Accidental Impulsivity Firstattempt NoofPreviousattempts Date_Ingestion IngestHrs IngMins Date_Presentation PresHrs PresMns
patient already usingWATER chronic illness deliberate impulsive first attempt . 06-05-10 14 30 06-05-10 15 50
patient already usingWATER chronic illness deliberate impulsive first attempt . 03-02-10 10 0 03-02-10 14 30
home UNKNOWN partner conflict deliberate impulsive first attempt . 31-03-10 19 30 31-03-10 21 0
store/pharmacy WATER psychiatric illness deliberate pre-meditated first attempt . 19-04-10 22 0 19-04-10 23 20
patient already usingWATER family conflict(non partner) deliberate impulsive first attempt . 28-05-10 1 0 28-05-10 2 20
home WATER poor academic performance deliberate impulsive first attempt . 29-04-10 8 0 29-04-10 11 30
home WATER psychiatric illness deliberate impulsive first attempt . 28-02-10 10 30 28-02-10 15 30
home WATER chronic illness deliberate impulsive first attempt . 05-03-10 13 45 05-03-10 16 0
family member usingWATER family conflict(non partner) deliberate impulsive first attempt . 28-04-10 4 0 28-04-10 8 40
store/pharmacy UNKNOWN partner conflict deliberate impulsive first attempt . 07-01-10 20 0 07-01-10 23 30
store/pharmacy DIRECTLY multiple stressors deliberate pre-meditated previous attempt 1 20-01-10 2 30 20-01-10 4 50
home WATER unknown deliberate impulsive first attempt . 07-01-10 18 30 07-01-10 21 30
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 11-04-10 18 0 11-04-10 20 35
home WATER partner conflict deliberate impulsive first attempt . 01-01-10 18 0 01-01-10 22 30
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 06-01-10 17 0 06-01-10 22 0
store/pharmacy OTHER partner conflict deliberate impulsive first attempt . 07-01-10 19 0 07-01-10 19 30
home DIRECTLY partner conflict deliberate impulsive first attempt . 13-01-10 19 30 13-01-10 22 0
store/pharmacy WATER family conflict(non partner) deliberate pre-meditated first attempt . 13-01-10 15 30 13-01-10 22 25
patient already usingWATER chronic illness deliberate impulsive first attempt . 13-01-10 6 0 13-01-10 22 45
store/pharmacy ALCOHOL multiple stressors deliberate impulsive first attempt . 13-01-10 18 30 13-01-10 23 10
store/pharmacy WATER partner conflict deliberate impulsive previous attempt 1 13-01-10 22 0 14-01-10 1 50
store/pharmacy DIRECTLY partner conflict deliberate impulsive first attempt . 17-01-10 12 0 17-01-10 17 45
home WATER family conflict(non partner) deliberate impulsive first attempt . 17-01-10 17 0 17-01-10 20 0
patient already usingWATER chronic illness deliberate impulsive first attempt . 17-01-10 14 0 17-01-10 20 20
patient already usingWATER poor academic performance deliberate impulsive first attempt . 18-01-10 0 0 18-01-10 7 30
99 DIRECTLY others accidental . first attempt . 20-01-10 11 0 20-01-10 13 25
family member usingWATER partner conflict deliberate impulsive first attempt . 20-01-10 16 0 20-01-10 17 20
home DIRECTLY multiple stressors deliberate impulsive first attempt . 24-01-10 17 0 24-01-10 18 25
home WATER family conflict(non partner) deliberate pre-meditated first attempt . 25-01-10 13 0 25-01-10 14 0
home OTHER job difficulty deliberate pre-meditated first attempt . 27-01-10 17 50 27-01-10 19 0
store/pharmacy OTHER job difficulty deliberate impulsive first attempt . 30-01-10 10 30 30-01-10 23 20
store/pharmacy ALCOHOL partner conflict deliberate pre-meditated first attempt . 01-02-10 11 30 01-02-10 16 50
home DIRECTLY partner conflict deliberate impulsive first attempt . 02-02-10 13 30 02-02-10 16 30
home OTHER job difficulty deliberate pre-meditated first attempt . 30-01-10 6 0 30-01-10 23 0
store/pharmacy WATER job difficulty deliberate impulsive first attempt . 03-02-10 13 30 03-02-10 16 10
store/pharmacy WATER family conflict(non partner) deliberate impulsive first attempt . 03-02-10 14 0 03-02-10 17 40
store/pharmacy ALCOHOL partner conflict deliberate impulsive first attempt . 11-02-10 16 0 11-02-10 20 20
home ALCOHOL job difficulty deliberate impulsive first attempt . 18-02-10 18 30 18-02-10 22 45
home WATER chronic illness deliberate impulsive first attempt . 21-02-10 19 0 22-02-10 13 15
home DIRECTLY multiple stressors deliberate impulsive first attempt . 20-02-10 5 0 20-02-10 10 25
patient already usingWATER family conflict(non partner) deliberate impulsive first attempt . 20-02-10 10 0 20-02-10 15 25
store/pharmacy DIRECTLY chronic illness deliberate . first attempt . 23-02-10 14 0 23-02-10 20 40
home DIRECTLY unknown deliberate impulsive first attempt . 24-02-10 18 0 24-02-10 20 30
family member usingWATER family conflict(non partner) deliberate impulsive first attempt . 26-02-10 21 0 27-02-10 15 0
store/pharmacy ALCOHOL job difficulty deliberate impulsive first attempt . 06-03-10 21 0 07-03-10 0 40
home UNKNOWN others accidental . first attempt . 07-03-10 1 0 07-03-10 6 0
home WATER job difficulty deliberate impulsive first attempt . 07-03-10 6 30 07-03-10 9 30
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 07-03-10 16 30 07-03-10 18 20
home WATER unknown deliberate impulsive first attempt . 10-03-10 11 0 10-03-10 17 0
patient already usingWATER others accidental . first attempt . 11-03-10 20 0 12-03-10 19 0
home WATER family conflict(non partner) deliberate impulsive first attempt . 13-03-10 11 0 13-03-10 16 40
home DIRECTLY others accidental . first attempt . 15-03-10 12 30 15-03-10 17 0
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 22-03-10 21 0 23-03-10 6 45
home DIRECTLY partner conflict deliberate impulsive first attempt . 24-03-10 21 30 24-03-10 23 40
home UNKNOWN partner conflict . . first attempt . 02-04-10 15 0 02-04-10 15 55
store/pharmacy WATER job difficulty deliberate impulsive first attempt . 02-04-10 21 10 06-04-10 10 0
patient already usingWATER job difficulty deliberate impulsive first attempt . 10-04-10 2 0 10-04-10 11 20
patient already usingUNKNOWN partner conflict deliberate . first attempt . 11-04-10 9 0 11-04-10 15 0






























































symptom1 symptom2 symptom3 symptom4 symptom5 symptom6 symptom7 Sign1 Sign2 Sign3 Sign4 Sign5 Pulse DiastolicBP SystolicBP RespiratoryRate O2Saturation
99 . . . . . . 99 . . . . 95 70 100 22 98
14 2 . . . . . 1 . . . . 70 70 100 20 96
15 . . . . . . 99 . . . . 56 70 100 24 98
1 . . . . . . 99 . . . . 80 100 160 24 100
14 19 . . . . . 99 . . . . 66 90 120 24 98
2 . . . . . . 99 . . . . 90 70 100 22 98
14 5 . . . . . 2 . . . . 98 70 110 22 96
16 2 . . . . . 17 . . . . 102 60 110 24 96
3 . . . . . . 99 . . . . 110 60 100 24 99
3 . . . . . . 99 . . . . 84 60 90 24 99
14 16 27 17 21 . . 31 20 . . . 102 90 130 24 98
4 3 . . . . . 3 11 11 . . 96 70 100 20 97
17 20 27 . . . . 30 21 . . . 114 90 130 22 98
14 1 7 2 . . . 4 . . . . 84 80 120 24 98
14 27 3 . . . . 32 . . . . 24 70 100 24 98
14 . . . . . . 4 . . . . 120 100 130 24 97
14 27 17 20 23 . . 30 30 . . . 94 80 120 24 .
16 3 . . . . . 18 7 . . . 80 70 90 . 98
3 2 8 . . . . 99 . . . . 144 70 90 20 94
5 28 . . . . . 4 . . . . 124 80 130 24 99
14 19 16 . . . . 28 22 19 . . 64 80 130 24 78
14 4 . . . . . 99 . . . . 124 80 130 24 98
17 . . . . . . 99 . . . . 124 70 90 24 98
14 4 . . . . . 5 6 5 8 . 130 80 130 24 98
14 . . . . . . 99 . . . . 98 80 130 24 98
14 27 17 . . . . 30 19 34 . . 82 90 150 24 98
3 . . . . . . 6 . . . . 124 60 100 20 96
14 27 22 16 . . . 19 23 30 . . 96 70 110 24 100
3 . . . . . . 99 . . . . 124 80 120 28 100
14 27 22 5 17 20 23 30 30 35 23 19 91 80 110 32 78
4 2 5 . . . . 7 . . . . 124 80 104 32 96
99 . . . . . . 99 . . . . 112 70 110 22 100
4 2 . . . . . 8 . . . . 135 60 100 20 94
14 19 27 2 . . . 30 . . . . 80 80 120 20 98
2 . . . . . . 9 8 . . . 92 70 100 24 97
14 2 15 . . . . 99 . . . . 112 90 130 22 94
14 . . . . . . 99 . . . . 124 80 120 20 96
14 . . . . . . 99 . . . . 104 80 130 24 99
5 6 9 . . . . 6 . . . . 124 90 150 26 96
14 . . . . . . 99 . . . . 112 70 100 24 97
3 . . . . . . 2 . . . . 124 80 110 22 98
99 . . . . . . 99 . . . . 116 60 90 24 96
99 . . . . . . 99 . . . . 101 80 110 22 98
5 . . . . . . 1 4 7 . . 143 90 150 24 98
14 . . . . . . 99 . . . . 110 80 130 24 99
17 15 21 . . . . 34 . . . . 72 70 110 20 97
14 . . . . . . 99 . . . . 80 80 120 15 96
14 . . . . . . 99 . . . . 86 70 100 20 96
14 . . . . . . 99 . . . . 96 60 110 22 98
27 . . . . . . 8 13 . . . 112 80 110 20 97
99 . . . . . . 99 . . . . 112 60 90 24 97
18 27 . . . . . 99 . . . . 112 70 100 20 97
27 16 10 15 2 . . 30 . . . . 84 70 100 24 97
14 . . . . . . 99 . . . . 90 70 110 20 98
4 . . . . . . 10 . . . . 170 140 160 40 88
21 7 3 26 . . . 29 . . . . . . . . .
5 24 . . . . . 2 15 . . . 92 70 100 26 96
5 . . . . . . 7 . . . . 108 90 130 28 96






























































Temperature GRBS GCS PupilSize CXRNormal ECGNormal ECGrate1st PRinterval1st @1stQTC ECGother1st vSodium vPotassium vHCO3 vCalcium vPhosporous
98 90 15 4 1 199 . . . . 148 3.8 21 . .
97 109 15 4 1 1 50 174 422 . 135 3.7 21 . .
98 94 15 4 1 1 50 158 384 . 137 3.9 20 . .
98 95 15 4 1 1 . . . . 133 3.0 18 . .
98 101 15 4 1 1 60 198 418 . 139 3.6 22 . .
98 120 15 4 1 1 . . . . 141 3.1 25 . .
98 147 15 3 1 1 100 146 408 . 135 3.0 17 . .
98 106 15 4 1 1 100 140 399 . 140 3.7 23 . .
98 83 15 4 1 1 . . . . 139 3.6 18 . .
. 120 15 3 1 1 80 158 445 . 138 3.9 18 . .
98 264 15 4 1 1 75 150 441 . 135 4.1 19 . .
. 94 8 2 1 1 80 150 322 INCOMPLETE RBBB 136 3.3 23 4.2 2
98 113 15 4 1 1 . . . . 144 3.5 22 . .
98 108 15 5 1 1 100 160 428 . 142 3.2 22 . .
98 95 15 5 1 1 100 134 415 . 137 3.9 19 . .
98 108 15 4 1 1 130 154 431 . 138 3.6 20 . .
99 159 15 5 1 1 110 146 441 LOW VOLTAGE QRS 141 3.6 21 4.1 .
98 103 10 . 199 1 75 168 397 . 141 3.1 25 . .
. 166 15 5 1 1 . . . . 140 3.7 23 . .
98 124 6 1 1 1 . . . . 137 3.3 24 . .
98 159 15 4 2 1 150 112 480 . 137 4.9 22 . .
98 239 15 5 1 1 . . . . 137 3.3 19 . .
98 90 15 5 1 1 . . . . 137 3.8 20 . .
98 137 14 5 1 1 120 154 406 ST DEPRESSIONS, T INVERSIONS 137 3.0 22 . .
98 180 15 6 1 1 75 144 442 NON SPECIFIC ST DEPRESSION 136 3.3 15 9.6 2
98 . 15 4 1 1 87 156 412 . 132 4.4 24 . .
98 98 15 5 1 199 . . . . 136 3.2 22 . .
98 239 15 . 1 1 80 120 409 . 138 3.4 15 . .
98 101 15 5 1 1 80 154 408 . 143 2.8 18 . .
98 76 13 . 1 1 . . . . 135 4.0 20 . .
99 117 12 5 1 1 56 102 433 . 139 3.0 24 . .
99 92 15 4 1 1 . . . . 139 3.2 22 . .
98 . 3 3 1 1 . . . . 144 5.5 8 . .
99 116 15 4 1 1 70 148 404 . 138 3.4 17 . .
98 109 15 6 1 1 72 154 411 . 136 3.6 21 . .
98 98 14 3 199 1 130 150 481 . 137 3.8 19 . .
98 83 15 4 1 1 . . . . 137 2.7 17 . .
. 109 15 4 1 1 100 88 418 . 139 3.3 22 . .
98 132 15 4 1 2 130 144 472 . . . . . .
98 127 15 4 1 1 100 138 454 . 137 3.2 22 . .
98 102 15 4 1 1 100 106 412 . 137 3.8 18 . .
100 101 15 6 1 1 . . . . 145 3.6 24 . .
98 101 15 4 1 1 100 138 466 . 137 3.9 21 . .
104 140 . 3 1 1 130 . 409 . 140 3.9 21 . .
98 114 15 4 1 1 100 144 412 . 144 3.4 17 . .
98 229 15 4 1 1 100 194 472 . 137 3.4 20 . .
98 . 15 4 1 1 . . . . 135 2.1 20 . .
98 85 15 4 1 1 . . . . 140 2.6 23 . .
98 109 15 3 1 1 75 120 430 . 139 3.5 18 . .
98 . 15 4 1 1 . . . . 136 3.8 23 . .
98 97 15 4 1 1 . . . . 139 3.5 24 . .
98 100 15 5 1 1 . . . . 141 3.6 19 . .
98 124 15 4 1 1 100 192 474 . 139 3.3 23 . .
98 94 15 4 1 1 120 140 442 . 138 3.4 20 . .
98 181 3 6 1 1 . . . . 154 3.6 15 . .
. . . . 1 1 . . . . 132 4.8 16 8.0 3
98 120 13 2 1 1 100 168 396 . 137 3.1 22 . .
98 109 9 2 1 1 120 152 400 . 134 3.3 23 . .






























































TotalBilirubin directBilirubin TotalProtein Albumin SGOT SGPT AlkalinePhosphatase Creatinine Urea PriorTreatmentelsewhere Priormethod OutsideCentre Admission Duration
. . . . . . . 0.6 . 1 . home no 0
. . . . . . . . . 1 199 home no 0
. . . . . . . 0.7 . 1 . home no 0
. . . . . . . 0.9 . 1 . home no 0
. . . . . . . 1.0 . 1 . home no 0
. . . . . . . 0.9 . 1 . home no 0
0.5 0.2 7.9 4.5 12 14 51 0.8 . 1 7 private hosp yes 5
0.4 0.1 7.9 4.4 20 10 65 0.9 . 1 . home yes 1
. . . . . . . 0.9 . 1 . home no 0
0.4 0.2 8.8 4.5 21 14 12 0.9 15 1 . home no 0
. . . . . . . 1.1 . 1 . home yes 6
0.5 0.2 6.9 4.2 17 31 82 0.8 . 1 . home yes 4
. . . . . . . 0.8 . 2 gastric lavage government hosp no 0
. . . . . . . 0.7 . 2 5 government hosp no 0
. . . . . . . 1.1 . 1 . home no 0
. . . . . . . 1.0 . 1 . home no 0
0.7 0.2 8.0 4.5 18 8 82 0.7 . 1 . home yes 4
0.4 0.2 8.5 4.7 17 5 44 0.5 . 2 Forced emesis private hosp DAMA 1
. . . . . . . 0.6 . 1 gastric lavage government hosp no 0
. . . . . . . 0.8 16 2 gastric lavage government hosp yes 2
. . . . . . . 1.3 19 2 gastric lavage government hosp yes 1
7.0 0.1 8.7 5.8 57 10 80 1.1 . 2 . government hosp Referred 0
. . . . . . . . . 2 Forced emesis government hosp no 0
. . . . . . . 0.9 . 2 Forced emesis government hosp no 0
0.6 0.2 8.6 4.8 31 18 112 0.8 22 1 . home yes 1
. . . . . . . 0.9 . 2 4 home no 0
1.0 0.3 7.9 4.6 16 10 51 0.8 . 1 . home no 0
. . . . . . . 1.0 . 99 . unknown yes 5
. . . . . . . 0.7 . 1 . home no 0
0.8 0.1 9.9 4.8 29 16 128 1.0 17 1 . home yes 1
. . . . . . . . . 2 5 government hosp no 0
. . . . . . . 0.9 . 2 4 private hosp no 0
. . . . . . . 1.2 . 2 gastric lavage unknown no 0
. . . . . . . 1.1 . 1 . home no 0
. . . . . . . 0.8 . 2 gastric lavage government hosp no 0
. . . . . . . 0.9 . 2 gastric lavage home no 0
. . . . . . . 1.2 43 2 Forced emesis government hosp no 0
. . . . . . . 1.0 . 2 gastric lavage private hosp no 0
. 0.2 . . 16 10 . . . 2 4 government hosp no 0
. . . . . . . 0.6 . 2 gastric lavage government hosp no 0
. . . . . . . 0.7 . 1 199 home no 0
. . . . . . . 1.2 . 1 . home no 0
. . . . . . . 0.7 . 1 . home no 0
. . . . . . . 0.9 . 2 gastric lavage government hosp yes 4
. . . . . . . 0.9 . 2 5 government hosp yes 1
. . . . . . . 0.9 . 2 Forced emesis home yes 6
. . . . . . . 1.0 . 1 . home no 0
. . . . . . . 0.8 . 1 . home no 0
0.5 0.2 8.4 4.2 17 10 54 . . 2 . home no 0
0.4 0.2 8.4 4.4 17 10 65 0.7 . 99 . unknown no 0
. . . . . . . 0.8 . 2 gastric lavage unknown no 0
. . . . . . . 0.9 . 1 . home no 0
0.6 0.2 8.4 5.0 256 32 79 0.9 . 2 4 government hosp no 5
. . . . . . . 0.7 . 1 Forced emesis government hosp no 0
. . . . . . . 1.3 . 1 . home yes 1
8.4 3.8 6.9 4.2 608 487 76 1.8 29 2 6 private hosp DAMA 3
. . . . . . . . . 1 . home no 0
. . . . . . . 0.8 . 2 gastric lavage government hosp yes 2






























































icuhdu Intubated MethodDecontamination CharcoalGiven @1stcomplication @2ndcomplications @3rdcomplications @4thcomplications @5thcomplications sbpsych psychdiagnosis substabuse
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes none . . . . PSYCHIATRISTBPAD alcohol
excluded no orogastric tube yes unknown . . . . unknown unknown unknown
excluded no orogastric tube yes unknown . . . . unknown unknown unknown
excluded no orogastric tube yes none . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes Loss of consc. . . . . NOT SEEN excluded none
excluded no orogastric tube yes none . . . . PSYCHIATRISTNORMAL none
excluded no none yes none . . . . PSYCHIATRISTunknown none
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes none . . . . PSYCHIATRISTMARITAL DISCORD none
excluded yes none yes STOM 3A OESO 3 Pyloric Stenosis peritonitis ORAL ULCER PSYCHIATRISTALCOHOL DEPENDANCEalcohol
yes yes orogastric tube yes unknown . . . . unknown unknown unknown
excluded no none yes STOM 1 . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes none . . . . NOT SEEN excluded none
excluded no none yes skin reaction . . . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes none . . . . PSYCHIATRISTDEPRESSION alcohol
no no none yes STOM 3A OESO 2A . . . SOCIAL WORKERexcluded none
no no none yes hypotension . . . . SOCIAL WORKERexcluded none
excluded no nasogastric tube yes none . . . . PSYCHIATRISTDEPRESSION none
no yes orogastric tube yes respiratory failure . . . . PSYCHIATRISTADJUSTMENT DISORDERalcohol
no no none yes metabolic acidosis . . . . NOT SEEN excluded none
excluded no orogastric tube yes seizures . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no others yes none . . . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes seizures delirium . . . PSYCHIATRISTNORMAL none
no no none yes none . . . . PSYCHIATRISTNORMAL none
excluded no others yes OESO 2A ORAL ULCER . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
no no none no DUODENUM Pyloric Stenosis . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
yes yes none yes respiratory failure . . . . SOCIAL WORKERexcluded alcohol
excluded no none yes delirium . . . . SOCIAL WORKERexcluded alcohol
excluded no orogastric tube yes none . . . . PSYCHIATRISTDYSTHYMIA none
excluded no orogastric tube yes seizures metabolic acidosis . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no none yes ORAL ULCER . . . . SOCIAL WORKERexcluded alcohol
excluded no orogastric tube yes none . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes unknown . . . . unknown unknown unknown
excluded no none yes none . . . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes none . . . . PSYCHIATRISTADJUSTMENT DISORDERmultiple
excluded no none no delirium . . . . PSYCHIATRISTBPAD none
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded excluded
excluded no none yes unknown . . . . unknown unknown unknown
excluded no none yes none . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no none yes none . . . . PSYCHIATRISTNORMAL none
no no none yes aspiration pneumonia delirium . . . unknown unknown none
no no none yes none . . . . unknown unknown none
no no none yes OESO 2A OESO 2A . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes unknown . . . . unknown unknown unknown
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes none cerebellar dysf. . . . SOCIAL WORKERexcluded none
excluded no none no unknown cerebellar dysf. . . . SOCIAL WORKERBPAD none
excluded no none yes none . . . . SOCIAL WORKERexcluded none
excluded no none yes none . . . . PSYCHIATRISTNORMAL none
excluded no none no rhabdomyolysis . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube no none . . . . SOCIAL WORKERexcluded none
yes no none yes death . . . . unknown unknown unknown
no no none yes hepatitis coagulopathy . . . PSYCHIATRISTDYSTHYMIA none
excluded no none yes none . . . . PSYCHIATRISTDEPRESSION none
no no none yes delirium . . . . PSYCHIATRISTDEPRESSION none






























































treatpsych cSodium cPotassium cHCO3 cCalcium cPhosphorous electrolytes cTotalBilirubin cdirectBilirubin cTotalProtein cAlbumin cSGOT cSGPT cAlkalinePhosphatase cLFT
excluded 2.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 1.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 1.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 0.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 0.00 . . 1.00 . . . . . . . .
none 1.00 1.00 1.00 . . 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
unknown 0.00 0.00 0.00 . . . 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
excluded 0.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 0.00 1.00 . . 1.00 0.00 0.00 2.00 0.00 0.00 0.00 0.00 1.00
referral 1.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 1.00 0.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
referral 0.00 1.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 0.00 1.00 . . 1.00 . . . . . . . .
only pharmacological 0.00 0.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 0.00 1.00 1.00 . 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
excluded 0.00 1.00 0.00 . . 1.00 0.00 0.00 2.00 0.00 0.00 0.00 0.00 1.00
referral 0.00 0.00 0.00 . . . . . . . . . . .
referral 0.00 1.00 0.00 . . 1.00 . . . . . . . .
none 0.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 1.00 1.00 . . 1.00 2.00 0.00 2.00 2.00 2.00 0.00 0.00 1.00
none 0.00 0.00 1.00 . . 1.00 . . . . . . . .
none 0.00 1.00 1.00 . . 1.00 . . . . . . . .
none 0.00 1.00 1.00 0.00 1.00 1.00 0.00 0.00 2.00 0.00 0.00 0.00 0.00 1.00
excluded 1.00 0.00 0.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 1.00 . 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
excluded 1.00 0.00 1.00 . . 1.00 0.00 0.00 2.00 0.00 0.00 0.00 2.00 1.00
excluded 0.00 1.00 0.00 . . 1.00 . . . . . . . .
only pharmacological 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 2.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 0.00 1.00 . . 1.00 . . . . . . . .
none 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral . . . . . . . 0.00 . . 0.00 0.00 . .
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 2.00 0.00 0.00 . . 1.00 . . . . . . . .
none 0.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 0.00 1.00 . . 1.00 . . . . . . . .
unknown 0.00 1.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
unknown 1.00 1.00 1.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 0.00 . . 1.00 . . . . . . . .
excluded 0.00 1.00 1.00 . . 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
excluded 0.00 0.00 0.00 . . . 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
excluded 0.00 1.00 0.00 . . 1.00 . . . . . . . .
referral 0.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 0.00 1.00 0.00 . . 1.00 0.00 0.00 0.00 2.00 2.00 0.00 0.00 1.00
excluded 0.00 1.00 1.00 . . 1.00 . . . . . . . .
unknown 2.00 0.00 1.00 . . 1.00 . . . . . . . .
referral 1.00 0.00 1.00 1.00 0.00 1.00 2.00 2.00 0.00 0.00 2.00 2.00 0.00 1.00
referral 0.00 1.00 1.00 . . 1.00 . . . . . . . .
referral 1.00 1.00 0.00 . . 1.00 . . . . . . . .






























































cCreatinine cUrea cRFT xfemale timetopresentation pos_ghq pos_ghq_rev Rural GHQ_abov_3yClass
0.00 . . 1.00 1.33 0.00 6.00 urban no prescription drug
. . . 0.00 4.50 6.00 4.00 urban yes prescription drug
0.00 . . 1.00 1.50 1.00 5.00 urban no prescription drug
0.00 . . 1.00 1.33 10.00 4.00 rural yes prescription drug
0.00 . . 0.00 1.33 5.00 1.00 . yes prescription drug
0.00 . . 1.00 3.50 9.00 5.00 urban yes pesticide
0.00 . . 1.00 5.00 0.00 6.00 rural no prescription drug
0.00 . . 1.00 2.25 . . urban . prescription drug
0.00 . . 1.00 4.67 8.00 6.00 . yes prescription drug
0.00 0.00 0.00 0.00 3.50 . . rural . prescription drug
0.00 . . 1.00 2.33 0.00 6.00 . no corrosive/chemical
0.00 . . 0.00 3.00 . . rural . prescription drug
0.00 . . 1.00 2.58 3.00 9.00 rural no corrosive/chemical
0.00 . . 1.00 4.50 . . . . pesticide
0.00 . . 0.00 5.00 . . urban . prescription drug
0.00 . . 0.00 0.50 . . rural . pesticide
0.00 . . 1.00 2.50 . . . . corrosive/chemical
0.00 . . 1.00 6.92 . . rural . prescription drug
0.00 . . 1.00 16.75 . . urban . prescription drug
0.00 0.00 0.00 0.00 4.67 9.00 5.00 rural yes pesticide
0.00 0.00 0.00 0.00 3.83 . . rural . corrosive/chemical
0.00 . . 0.00 5.75 3.00 7.00 rural no pesticide
. . . 1.00 3.00 10.00 4.00 rural yes corrosive/chemical
0.00 . . 1.00 6.33 3.00 7.00 urban no prescription drug
0.00 0.00 0.00 0.00 7.50 7.00 5.00 rural yes prescription drug
0.00 . . 0.00 2.42 0.00 6.00 . no corrosive/chemical
0.00 . . 1.00 1.33 2.00 8.00 urban no prescription drug
0.00 . . 1.00 1.42 . . urban . corrosive/chemical
0.00 . . 1.00 1.00 9.00 3.00 urban yes prescription drug
0.00 0.00 0.00 0.00 1.17 . . rural . corrosive/chemical
. . . 0.00 12.83 3.00 7.00 urban no pesticide
0.00 . . 0.00 5.33 10.00 4.00 rural yes prescription drug
0.00 . . 1.00 3.00 8.00 6.00 rural yes pesticide
0.00 . . 0.00 17.00 11.00 5.00 rural yes corrosive/chemical
0.00 . . 0.00 2.67 1.00 5.00 rural no prescription drug
0.00 . . 0.00 3.67 3.00 5.00 . no prescription drug
0.00 2.00 2.00 0.00 4.33 0.00 6.00 rural no pesticide
0.00 . . 0.00 4.25 0.00 6.00 rural no pesticide
. . . 1.00 18.25 . . rural . prescription drug
0.00 . . 1.00 5.42 2.00 5.00 rural no pesticide
0.00 . . 0.00 5.42 7.00 11.00 rural yes prescription drug
0.00 . . 0.00 6.67 . . urban . pesticide
0.00 . . 1.00 2.50 3.00 3.00 . no pesticide
0.00 . . 0.00 18.00 . . rural . prescription drug
0.00 . . 0.00 3.67 1.00 7.00 . no pesticide
0.00 . . 1.00 5.00 . . urban . corrosive/chemical
0.00 . . 0.00 3.00 10.00 6.00 urban yes pesticide
0.00 . . 1.00 1.83 0.00 6.00 urban no corrosive/chemical
. . . 1.00 6.00 3.00 7.00 . no prescription drug
0.00 . . 1.00 23.00 . . urban . prescription drug
0.00 . . 0.00 5.67 0.00 6.00 urban no prescription drug
0.00 . . 1.00 4.50 . . . . corrosive/chemical
0.00 . . 1.00 9.75 . . rural . corrosive/chemical
0.00 . . 1.00 2.17 . . rural . corrosive/chemical
0.00 . . 0.00 0.92 . . rural . pesticide
2.00 0.00 2.00 0.00 84.83 6.00 2.00 rural yes pesticide
. . . 0.00 9.33 6.00 8.00 urban yes prescription drug
0.00 . . 1.00 6.00 . . . . prescription drug
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HospNo Name Age Sex Address Education Occupation multiplepoisons P_Class1 PoisonCode1 P_Class2 PoisonCode2
674114D BHARATI 37 2 126, M.C. R COLONY  TIRUPATHI  TIRUPATHI  ANDHRA PRADESHgraduate teacher no DRUG ANTI HYPERTENSIVE . .
674344D DURGA N 31 2 ANBOONDI  POIGAI  VELLORE   TAMIL NADU6th housewife no INSECTICIDE FERTILISER . .
674348D TAMILARASAN 26 1 KOTTAI ST,  KAVERIPAKKAM  KAVERIPAKKAM  VELLOREhigher secondary mason no RODENTICIDE PHOSPHOROUS . .
674379D BALAJI R 38 1 20 V.O.C. NAGAR  SATHUVACHARI  VELLORE6th driver no INSECTICIDE ORGANOCHLORIDE(OTHER) . .
674388D SELVARAJ 45 1 PILLAYAR KOIL ST  CHINNAKALLUPALLI  KALANDHIRA POVE  VELLORE  TAMIL NADUhigher secondary others no DRUG BENZODIAZEPENE . .
674507D THENMOZHI 19 2 SERLAPALLI  PERNAMPET  GUDIYATHAM TK VELLOREhigher secondary student no NON INGESTED ANALGESIC(OTHER) . .
676108D DEEPA 27 2 49-A,V.T.K.NAGAR  KATPADI  VELLORE  TAMIL NADU  PHONE 80151146137th housewife no DRUG PARACETAMOL . .
678045D Janani S 20 2 118-2,PUDUKUDIYAN SATRAM ST.,  THOTTAPALAYAM,  VELLORE  TAMIL NADUhigher secondary housewife no DRUG NEWER ANTIDEPRESSANT . .
680037D RAJASEKAR 26 1 PERUMAL KOIL STREET  KARIGIRI  KARIGIRI  VELLORE  TAMIL NADUhigher secondary driver no INSECTICIDE PYRETHROID . .
680054D HABEEBA 56 2 3 KASAI ABDUL KARIM ST  R N PALAYAM  VELLORE  TAMIL NADUNIL housewife yes DRUG PHENOTHIAZIENE DRUG PHENOTHIAZIENE
680069D RAMYA M 22 2 53 FIRST CROSS  BHARATHI NAGAR  KANIYAMBADI  VELLORE  TAMIL NADU  9994615233postgraduate student no CORROSIVE/CHEMICAL AMMONIUM DERIVATIVE . .
680350D TENNIS R 22 1 47, AROKIYAMADHA STREET  CHETPET  POLUR  T.V.MALAI  TAMIL NADUNIL mason no INSECTICIDE ENDOSULFAN . .
686124D SEETHA T 22 2 1/98 MELPATTI STREET  KARIGIRI  VELLORE6th housewife no CORROSIVE/CHEMICAL HYDROCARBON . .
686361D AFREEN 23 2 72/9,KASIM KUMANDAN STREET  SAIDAPET  VELLORE  TAMIL NADU10th housewife no DRUG ANTIPSYCHOTIC . .
686484D PRIYA M 19 2 MANTHOPPU MEDU EDAYAMPATTI  VELLORE TK  VELLOREgraduate housewife no CORROSIVE/CHEMICAL PHENOL/ORGANIC ACID . .
686507D VENNILA 21 2 46, MUPPANAR NAGAR  EDAYANSATHU  VIRUPATCHIPURAM VELLORE10th housewife no DRUG PARACETAMOL . .
686572d KHADEEJA BANU P.T. 19 2 70, MADEENA NAGAR  VIRUTHAMPET  VELLORE10th unemployed no DRUG PHENOTHIAZIENE . .
68817D INDRA KUMARI 20 2 ANNA NAGAR  IRUNAMPATTU  VANIYAMBADI  VELLORE10th unemployed no INSECTICIDE PYRETHROID . .
688487D NITHYAVANI 20 1 NO 75 NVN STREET  WINTERPET  ARAKKONAM   VELLOREgraduate others no DRUG PARACETAMOL . .
688744D NITHIYA A 19 2 PV.PURAM  NELLAGONDA PURLAYAM    K.V.KUPPAM RUSHA  KATPADI TK VELLORE10th housewife no CORROSIVE/CHEMICAL PHENOL/ORGANIC ACID . .
689833D REVATHI P 26 2 MELPATTI STREET  KARIGIRI PARAI MEDU  KAMMARPUDUR   VELLOREhigher secondary unemployed no INSECTICIDE INSECTICIDE(UNKNOWN) . .
693243D SUMITHRA 18 2 RAMESH HOUSE  KILARASAM PET  VELLORE  VELLOREhigher secondary student no CORROSIVE/CHEMICAL INORGANIC ACID . .
693326D SATHIYA E. 17 2 94,CHURCH ST.,  PONNAI  KATPADI VELLOREgraduate unemployed no DRUG ORAL HYPOGLYCEMIC . .
693452D KAVIPRIYA R 18 2 38, THENDRAL NAGAR  VENGIKKAL  VENGIKKAL   THIRUVANNAMALAIhigher secondary student no DRUG ANTI-EPILEPTIC . .
693537D GOWRI 19 2 516,MANICKA NAICKER ST.  VIRUTHAMPET  KATPADI   VELLOREhigher secondary housewife yes DRUG UNKNOWN TAB DRUG UNKNOWN TAB
69669D THENMOZHI 18 2 9/15 PERUMALKUPPAM  VELLORE TAMILNADUNIL unemployed no INSECTICIDE PYRETHROID . .
701124D ELUMALAI V 35 1 108B,VADAKU KOTTAI  SE.AGARAM  PALIYAPATTU   TIRUVANNAMALAI  TAMIL NADU<5th driver no INSECTICIDE INSECTICIDE(UNKNOWN) . .
701430D ARUL MOZHI 38 1 ACHUTHA KOVIL STREET  KANNAMANGALAM  VELLORE   TAMIL NADU  VELLORE 632311graduate farmer no DRUG BENZODIAZEPENE . .
701479D REKHA S 25 2 232 THIPPAI MEDU  MUNJURPET  VELLORE  TAMIL NADU  6320576th housewife no DRUG UNKNOWN TAB . .
701578D CHANDRA R 29 2 24/64 DIVERSION ROAD  POLUR  POLUR   TIRUVANAMALAI10th housewife yes DRUG ANTIPSYCHOTIC DRUG NEWER ANTIDEPRESSANT
701586D GUNASEKAR B 39 1 V.O.C NAGAR  WALAJAH  WALAJAPET VELLORE  TAMIL NADU  6324018th others no DRUG ANTI-EPILEPTIC . .
708141D KAMATCHI 29 2 101, RAMAR KOIL STREET,  PERUMUGAI  VELLORE  TAMIL NADU 63200910th housewife no DRUG NEWER ANTIDEPRESSANT . .
708153D KOKILA 26 2 13/4,ENGINEER SUSBRAYAN STREET  VELLORE  TAMIL NADU 632001graduate housewife no DRUG PARACETAMOL . .
708221D M. SARASWATHY 16 2 VADUVANTHANGAL,  K.V.KUPPAM  KATPADI  VELLORE10th student no CORROSIVE/CHEMICAL VASMOL DYE . .
709781D AMUDHA S 28 2 1/3, PULIYANTHANGAL  RANIPET  WALAJAPET VELLORE7th housewife no OTHER FUNGICIDE . .
712495D SASI KUMAR. M 30 1 REDDY VALSAI  NACHIYAR KUPPAM  VANIYAMBADI VELLORE  TAMIL NADU  9751847599NIL others no INSECTICIDE ENDOSULFAN . .
718142D RAMESH 27 1 40, GANDHI NAGAR  KANSALPET  VELLORE  TAMIL NADUdiploma MISSING yes INSECTICIDE PYRETHROID INSECTICIDE PYRETHROID
719137D KUMARAGURUBARAN S. 28 1 NO.13/25 BAJANAI KOIL STREET  PALLIKONDA  VELLORE  TAMIL NADU  9442244720graduate others no CORROSIVE/CHEMICAL INORGANIC ACID . .
719152D UMA V. 16 2 N S K NAGAR 6TH STREET  NELLORE PET  GUDIYATTAM VELLORE  TAMIL NADU10th student no INSECTICIDE UNKNOWN RODENTICIDE . .
719179D JAYALAKSHMI 35 2 THAIYUR  SR PURAM MANDAL CHITTOOR  ANDHRA PRADESH  90000960516th housewife no DRUG UNKNOWN TAB . .
719260D SRINIVASULU.G 21 1 PALAMNER,  CHITTOOR 10th labourer no INSECTICIDE PYRETHROID . .
719292D CHINNA SWAMY .J 29 1 ARUNAPATHY  KRISHNAGIRI  TAMIL NADU6th mason no INSECTICIDE INSECTICIDE(UNKNOWN) . .
720225A DEVASAGAYAM.K 41 1 1.MUNICIPAL COLONY,  KAGITHAPETTI.  VELLOREhigher secondary CMCemployee no CORROSIVE/CHEMICAL PHENOL/ORGANIC ACID . .
724141d MOHAMMED TANVEER 33 1 25 OLD POST OFFICE STREET  MEL VISHARAM  WALAJAPET VELLORE  TAMIL NADU  632509  80157963936th unemployed no DRUG PARACETAMOL . .
766194A GNANASEKARAN 56 1 2/208  BAGAYAM VELLORE higher secondary CMCemployee no DRUG PHENOTHIAZIENE . .
777397C VIDYA R 24 2 NO 4, ATTUVARTHANGAL  KORNAMPET,  KATPADI VELLOREunknown housewife yes DRUG ANTIHISTAMINE DRUG ANTIHISTAMINE
799694C GNANARAJ 33 1 SIVARAJ  VILLAGE  VIRUTHAMPET POST  VELLORE   TAMIL NADU10th labourer no DRUG PHENOTHIAZIENE . .
837246B BHAVANI 15 2 2/14 VASANTHAPURAM, ,ARUMUGAMUDALIYAR ST.,VELLORE. ,,VELLORE ,T.NADU10th unemployed no DRUG PARACETAMOL . .
860491B VAIJAYANTHI MALA 32 2 D27,PHASE III, HOUSING BOARD  VALLALAR, SATHUVACHARI  VELLORE  TAMIL NADUNIL housewife no DRUG ANTI-EPILEPTIC . .
877061A JEGAN 19 1 3/21 EAST STREET,  KONAVATTAM, KONAVATTAM POST, VELLORE 13.higher secondary MISSING yes DRUG OPIOID DRUG PARACETAMOL
950143A PARAMESWARI 23 2 10/12,CHUNNAMBUKKARA STREET,  VELLORE  VELLOREunknown housewife no DRUG UNKNOWN TAB . .























































P_Class3 PoisonCode3 P_Class4 PoisonCode4 P_Class5 PoisonCode5Amount1 Amount2 Amount3 Amount4 Amount5 Dose1 Dose2 Dose3 Dose4 Dose5 Units Placeofingestion
. . . . . . 30 . . . . 300 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . other
. . . . . . 20 . . . . 0 0 0 0 0 . other
. . . . . . 7 . . . . 4 0 0 0 0 . home
. . . . . . 2 . . . . 50 0 0 0 0 . home
. . . . . . 10 . . . . 5,000 0 0 0 0 . home
. . . . . . 30 . . . . 750 0 0 0 0 . home
. . . . . . 10 . . . . 500 0 0 0 0 . other
. . . . . . 10 10 . . . 750 500 0 0 0 . home
. . . . . . 200 . . . . 760 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . 10 . . . . 100 0 0 0 0 . home
. . . . . . 50 . . . . 0 0 0 0 0 . home
. . . . . . 18 . . . . 9,000 0 0 0 0 . home
. . . . . . 15 . . . . 375 0 0 0 0 . home
. . . . . . 10 . . . . 16 0 0 0 0 . home
. . . . . . 15 . . . . 7,500 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . 15 . . . . 7,500 0 0 0 0 . home
. . . . . . 20 . . . . 4,000 0 0 0 0 . home
DRUG UNKNOWN TAB . . . . 100 100 100 . . 0 0 0 0 0 . home
. . . . . . 1 . . . . 5 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 20 . . . . 5 0 0 0 0 . home
. . . . . . 10 . . . . 250 0 0 0 0 . home
. . . . . . 40 4 . . . 4,000 60 0 0 0 . home
. . . . . . 100 . . . . 10,000 0 0 0 0 . home
. . . . . . 40 . . . . 2,000 0 0 0 0 . home
. . . . . . 7 . . . . 3,500 0 0 0 0 . home
. . . . . . 50 . . . . 0 0 0 0 0 . home
. . . . . . 10 . . . . 0 0 0 0 0 . home
. . . . . . 150 . . . . 1,500 0 0 0 0 . home
. . . . . . 50 50 . . . 1 7 0 0 0 . home
. . . . . . 150 . . . . 0 0 0 0 0 . home
. . . . . . . . . . . 0 0 0 0 0 . other
. . . . . . 20 . . . . 0 0 0 0 0 . 99
. . . . . . 20 . . . . 0 0 0 0 0 . home
. . . . . . 100 . . . . 0 0 0 0 0 . other
. . . . . . . . . . . 0 0 0 0 0 . home
. . . . . . 15 . . . . 7,500 0 0 0 0 . home
. . . . . . 11 . . . . 275 0 0 0 0 . home
. . . . . . 40 10 . . . 400 250 0 0 0 . home
. . . . . . 80 . . . . 2,000 0 0 0 0 . home
. . . . . . 15 . . . . 7,500 0 0 0 0 . home
. . . . . . 40 . . . . 16,000 0 0 0 0 . home
. UNKNOWN TAB . . . . . . . . . . . . . . . home
. . . . . . . . . . . . . . . . . home























































Sourceofingestion Coingestant Reasonforpoisoning Accidental Impulsivity Firstattempt NoofPreviousattempts Date_Ingestion IngestHrs IngMins Date_Presentation PresHrs PresMns
patient already usingWATER partner conflict deliberate impulsive first attempt . 11-04-10 9 0 11-04-10 17 0
home DIRECTLY others deliberate pre-meditated first attempt . 16-04-10 17 0 16-04-10 18 55
store/pharmacy ALCOHOL family conflict(non partner) deliberate impulsive first attempt . 15-04-10 14 0 15-04-10 21 0
store/pharmacy WATER others deliberate impulsive first attempt . 16-04-10 14 30 16-04-10 16 45
patient already usingWATER others deliberate impulsive first attempt . 16-04-10 14 0 16-04-10 21 45
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 16-04-10 23 0 17-04-10 2 40
store/pharmacy WATER . deliberate impulsive first attempt . 12-04-10 18 30 12-04-10 21 40
family member usingWATER partner conflict deliberate impulsive first attempt . 15-04-10 21 0 16-04-10 1 30
store/pharmacy ALCOHOL others deliberate impulsive first attempt . 19-04-10 14 0 19-04-10 16 15
patient already usingWATER psychiatric illness deliberate pre-meditated first attempt . 19-04-10 13 30 19-04-10 22 10
home DIRECTLY partner conflict deliberate . first attempt . 20-04-10 0 30 20-04-10 7 0
store/pharmacy DIRECTLY family conflict(non partner) deliberate pre-meditated first attempt . 26-04-10 8 0 26-04-10 13 45
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 28-04-10 11 0 28-04-10 12 20
patient already usingWATER unknown deliberate impulsive first attempt . 07-05-10 10 0 07-05-10 14 45
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 03-05-10 13 0 03-05-10 15 0
patient already usingWATER psychiatric illness deliberate impulsive first attempt . 03-05-10 14 0 03-05-10 20 30
family member usingWATER multiple stressors deliberate impulsive first attempt . 04-05-10 19 0 04-05-10 23 0
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 01-05-10 7 30 01-05-10 10 30
home WATER psychiatric illness deliberate pre-meditated previous attempt 1 01-05-10 0 0 01-05-10 9 55
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 01-05-10 7 45 01-05-10 10 0
home UNKNOWN family conflict(non partner) deliberate impulsive first attempt . 05-05-10 10 0 05-05-10 11 15
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 11-05-10 5 0 11-05-10 8 45
home WATER family conflict(non partner) deliberate impulsive first attempt . 12-05-10 19 0 12-05-10 20 25
patient already usingWATER poor academic performance deliberate impulsive first attempt . 14-05-10 10 30 15-05-10 0 25
family member usingDIRECTLY family conflict(non partner) deliberate impulsive first attempt . 16-05-10 7 45 16-05-10 10 0
home WATER family conflict(non partner) deliberate impulsive first attempt . 04-04-10 13 0 04-04-10 15 50
99 ALCOHOL others deliberate . first attempt . 18-05-10 12 0 18-05-10 19 20
store/pharmacy ALCOHOL job difficulty deliberate impulsive first attempt . 24-05-10 22 0 25-05-10 0 10
patient already usingWATER psychiatric illness deliberate . first attempt . 25-05-10 16 0 25-05-10 22 0
patient already usingWATER partner conflict deliberate impulsive first attempt . 23-05-10 23 30 24-05-10 2 30
patient already usingDIRECTLY partner conflict deliberate impulsive first attempt . 24-05-10 1 0 24-05-10 7 0
patient already usingWATER family conflict(non partner) deliberate pre-meditated first attempt . 28-05-10 6 45 28-05-10 7 35
home WATER partner conflict deliberate impulsive first attempt . 29-05-10 11 0 29-05-10 12 30
family member usingUNKNOWN poor academic performance deliberate impulsive first attempt . 28-05-10 21 0 30-05-10 13 0
home WATER unknown deliberate impulsive first attempt . 02-06-10 19 0 02-06-10 22 0
store/pharmacy WATER others deliberate impulsive first attempt . 14-06-10 19 0 15-06-10 3 20
home UNKNOWN family conflict(non partner) deliberate impulsive first attempt . 16-06-10 10 30 16-06-10 11 0
home DIRECTLY family conflict(non partner) deliberate impulsive first attempt . 19-06-10 6 30 19-06-10 7 30
store/pharmacy UNKNOWN poor academic performance deliberate . first attempt . 19-06-10 9 0 19-06-10 11 30
99 UNKNOWN unknown . . first attempt . 20-06-10 14 30 20-06-10 19 0
home ALCOHOL family conflict(non partner) deliberate impulsive first attempt . 20-06-10 21 0 21-06-10 6 45
store/pharmacy UNKNOWN job difficulty deliberate pre-meditated first attempt . 21-06-10 11 0 21-06-10 20 35
home UNKNOWN psychiatric illness deliberate . previous attempt 1 08-03-10 9 0 08-03-10 17 0
home ALCOHOL family conflict(non partner) deliberate impulsive first attempt . 27-06-10 22 0 27-06-10 17 0
patient already usingWATER chronic illness deliberate . first attempt . 16-04-10 20 0 16-04-10 21 0
family member usingWATER partner conflict deliberate impulsive first attempt . 22-01-10 12 0 22-01-10 12 30
patient already usingWATER family conflict(non partner) deliberate impulsive first attempt . 17-06-10 10 30 17-06-10 14 25
home WATER family conflict(non partner) deliberate impulsive first attempt . 24-06-10 8 0 24-06-10 11 15
patient already usingUNKNOWN psychiatric illness accidental . previous attempt . 06-04-10 9 30 06-04-10 14 30
family member usingWATER others deliberate impulsive first attempt . 03-01-10 0 0 03-01-10 8 0
family member usingWATER chronic illness deliberate pre-meditated first attempt . 14-03-10 11 0 14-03-10 15 30























































symptom1 symptom2 symptom3 symptom4 symptom5 symptom6 symptom7 Sign1 Sign2 Sign3 Sign4 Sign5 Pulse DiastolicBP SystolicBP RespiratoryRate O2Saturation
99 . . . . . . 27 . . . . 80 . 80 22 96
16 5 . . . . . 99 . . . . 90 70 100 24 98
3 . . . . . . 17 . . . . 99 70 110 24 99
15 . . . . . . 99 . . . . 122 90 160 20 98
8 . . . . . . 2 . . . . 86 100 130 20 97
8 . . . . . . 99 . . . . . . . . .
14 . . . . . . 99 . . . . 86 70 100 22 97
5 12 6 . . . . 14 27 . . . 120 60 90 20 98
3 . . . . . . 99 . . . . 108 90 130 24 96
3 . . . . . . 9 . . . . 100 70 120 28 98
22 21 . . . . . 24 . . . . 135 70 100 . 88
4 5 . . . . . 10 . . . . 122 50 100 22 83
99 . . . . . . 99 . . . . 96 70 110 22 95
5 . . . . . . 15 . . . . 98 70 130 24 95
3 . . . . . . 99 . . . . 92 60 100 20 97
14 . . . . . . 99 . . . . 102 80 120 24 96
5 3 . . . . . 15 . . . . 152 90 150 28 100
4 . . . . . . 2 . . . . 124 70 110 28 88
3 . . . . . . 99 . . . . 96 90 130 20 99
17 20 . . . . . 99 . . . . 92 70 110 20 99
14 19 27 . . . . 99 . . . . 130 70 110 30 98
14 16 . . . . . 99 . . . . 104 60 120 28 96
3 . . . . . . 99 . . . . 80 70 110 24 100
11 2 . . . . . 8 13 13 6 . 112 70 110 24 96
2 . . . . . . 99 . . . . 152 60 150 22 97
99 . . . . . . 99 . . . . 116 90 130 24 96
14 5 22 3 . . . 25 . . . . 92 90 130 22 85
3 . . . . . . 2 . . . . 102 90 120 24 97
5 . . . . . . 7 . . . . 100 80 110 20 96
14 . . . . . . 99 . . . . 80 70 100 . 96
16 7 2 . . . . 8 . . . . 68 90 120 24 97
15 2 . . . . . 99 . . . . 88 70 120 24 96
99 . . . . . . 99 . . . . 90 70 110 24 99
22 29 . . . . . 19 . . . . 97 70 130 26 97
8 . . . . . . 30 4 . . . 104 80 110 26 98
4 5 . . . . . 14 14 . . . 128 80 130 30 100
5 17 . . . . . 2 . . . . 102 90 110 26 100
14 17 20 21 . . . 30 24 35 34 19 64 90 120 30 98
14 21 . . . . . 99 . . . . 156 80 120 48 95
14 3 5 . . . . 2 . . . . 110 110 140 32 96
3 . . . . . . 2 . . . . 88 60 100 28 96
5 . . . . . . 2 . . . . 92 60 90 22 97
8 13 . . . . . 16 . . . . . . . . .
99 . . . . . . 99 . . . . 90 80 120 22 97
3 . . . . . . 99 . . . . 120 90 130 32 96
2 25 . . . . . 6 . . . . 88 100 120 24 100
8 . . . . . . 99 . . . . . . . . 80
14 2 . . . . . 99 . . . . 102 60 100 26 100
8 30 . . . . . 7 7 . . . 102 70 110 30 100
27 3 . . . . . 99 . . . . 88 70 120 24 96
5 . . . . . . 7 . . . . 130 80 130 24 99























































Temperature GRBS GCS PupilSize CXRNormal ECGNormal ECGrate1st PRinterval1st @1stQTC ECGother1st vSodium vPotassium vHCO3 vCalcium vPhosporous
98 . 15 4 1 1 . . . . 141 3.6 20 . .
98 98 12 4 1 1 80 144 370 407 140 3.2 20 . .
98 84 15 4 1 1 . . . . 141 3.6 22 . .
98 126 15 3 1 1 80 144 415 . 137 3.1 18 8.9 1
98 145 . 3 1 1 80 132 436 . 138 4.0 22 . .
. . . . 1 1 . . . . 141 3.7 21 . .
98 226 15 4 1 1 . 146 402 . 137 4.0 13 8.6 .
98 132 15 3 1 1 130 188 398 . 141 3.5 17 . .
98 86 . 4 1 1 . . . . 139 3.3 18 . .
98 164 14 2 1 2 100 194 444 . 141 3.7 22 . .
. 177 . . 2 2 100 124 538 . . . . . .
98 111 6 2 1 1 . . . . 135 3.1 21 . .
98 81 15 4 2 1 . . . . 144 3.2 14 . .
98 89 14 4 1 1 100 88 397 . 156 4.2 18 . .
. 101 14 4 1 1 . . . . 140 3.3 16 . .
98 101 15 3 1 1 . 100 490 . . . . . .
98 116 10 3 1 2 120 150 406 . 139 3.2 22 . .
98 169 9 6 1 1 . . . . 141 3.2 15 . .
98 105 15 4 1 1 . . . . 144 3.9 18 . .
98 91 15 4 1 1 80 124 425 . 138 3.2 18 . .
98 108 15 4 1 1 100 126 442 . 147 4.2 17 . .
98 128 15 4 1 1 150 102 402 . 137 2.7 18 . .
98 121 15 . 1 1 . . . . 139 3.4 21 . .
98 138 14 4 1 1 . . . . 140 4.0 17 . .
. 174 15 . 2 1 . . . . 137 3.7 13 . .
98 81 15 4 1 1 100 150 397 . 142 3.6 21 . .
98 101 8 4 1 1 80 122 427 . 142 3.2 24 . .
98 117 15 6 1 1 140 114 429 . 141 3.7 19 . .
. . 6 6 1 1 110 190 . . 134 4.6 21 . .
98 96 15 . 1 1 90 194 560 . 138 3.2 20 . .
98 112 15 4 1 1 100 140 419 . 139 4.0 22 . .
98 190 15 3 1 1 . 156 462 . 136 3.3 23 . .
98 131 15 4 1 1 . . . . 142 3.5 21 . .
98 189 15 5 1 1 100 108 424 . 141 4.1 22 7.7 3
98 137 3 2 199 1 90 142 400 . 139 3.8 21 . .
98 198 10 4 1 1 100 160 418 . 145 4.6 13 . .
98 113 15 4 1 1 96 108 412 . 140 3.2 . . .
. . 14 3 1 1 . . . . 139 3.9 17 . .
101 . 15 . 1 1 150 114 420 . 138 4.0 10 . .
98 116 10 4 1 1 80 118 448 . 138 3.0 26 . .
99 120 15 4 1 1 80 130 404 . 142 3.2 21 . .
98 . 8 4 1 1 . . . . 146 3.6 22 . .
. . . 1 2 1 . . . . 137 5.1 10 . .
98 . 15 4 1 1 60 153 384 . 135 3.4 16 8.3 7
98 222 14 . 2 1 110 138 429 . 135 3.6 24 . .
98 . 15 5 1 1 88 138 433 . 135 3.5 21 . .
. . . . 1 1 . . . . 138 3.5 22 . .
98 . 15 . 1 1 100 116 481 . 142 3.8 21 . .
98 152 3 4 1 1 . . . . 138 3.6 19 . .
98 82 15 3 1 2 60 138 407 SINUS BRADYCARDIA 141 3.7 21 . .
98 126 8 2 1 1 . . . . 142 3.5 19 . .























































TotalBilirubin directBilirubin TotalProtein Albumin SGOT SGPT AlkalinePhosphatase Creatinine Urea PriorTreatmentelsewhere Priormethod OutsideCentre Admission Duration
. . . . . . . 1.1 . 2 gastric lavage government hosp yes 1
. . . . . . . 0.9 . 1 . home no 0
0.7 0.2 7.4 4.4 19 8 55 1.0 . 2 gastric lavage government hosp no 0
. . . . . . . 1.0 31 1 . home no 0
1.7 0.4 7.3 4.5 19 16 97 1.0 . 2 gastric lavage government hosp no 0
0.4 0.2 7.6 4.4 17 5 78 0.9 . 1 . home no 0
0.6 0.2 8.0 5.0 22 12 36 0.8 . 1 . home no 0
. . . . . . . 0.9 . 1 . home no 0
. . . . . . . 1.1 . 1 . home no 0
. . . . . . . 1.1 . 2 . home no 0
. . . . . . . 1.3 . 2 gastric lavage government hosp yes 41
0.6 0.2 6.8 3.9 46 12 62 1.4 . 2 5 private hosp yes 6
. . . . . . . 0.8 . 1 . home no 0
. . . . . . . 0.8 26 2 . private hosp no 0
. . . . . . . 0.9 . 2 . private hosp no 0
1.7 0.4 9.2 5.0 18 6 65 . . 1 . home no 0
. . . . . . . 1.0 . 1 . home yes 2
0.5 0.2 8.0 4.5 31 15 48 0.9 . 2 gastric lavage government hosp no 0
0.4 0.2 7.8 4.9 13 5 83 0.9 . 2 gastric lavage government hosp no 0
0.4 0.2 8.2 4.7 41 15 48 0.8 . 2 4 private hosp no 0
. . . . . . . 1.2 . 2 199 private hosp no 0
. . . . . . . 0.8 18 99 . unknown yes 13
. . . . . . . 0.8 . 1 . home no 0
. . . . . . . 0.9 . 1 . home no 0
. . . . . . . 0.9 . 1 . home no 0
. . . . . . . 0.8 . 2 gastric lavage home no 0
. . . . . . . 0.9 18 2 gastric lavage government hosp yes 1
. . . . . . . 1.2 . 2 gastric lavage government hosp no 0
. . . . . . . 0.7 . 2 gastric lavage private hosp no 0
0.5 0.1 6.7 3.9 15 10 39 0.9 . 2 . home no 0
. . . . . . . 1.2 . 2 gastric lavage private hosp no 0
0.4 0.1 8.1 4.9 28 28 56 0.9 . 1 . home no 0
. . . . . . . 0.9 28 1 . home no 0
0.6 0.2 7.7 4.0 3,259 523 63 0.8 22 2 gastric lavage government hosp yes 9
. . . . . . . 0.8 . 2 gastric lavage private hosp no 0
0.5 0.2 8.4 5.0 43 19 122 1.6 . 2 gastric lavage unknown yes 4
. . . . . . . 1.2 16 1 . home no 0
0.6 0.2 8.0 4.3 200 130 68 1.1 . 1 . home yes 11
0.9 0.2 8.6 4.5 1,779 1,460 118 1.5 32 2 5 government hosp yes 4
0.8 0.2 8.4 4.7 28 23 75 0.9 . 2 5 government hosp no 0
. . . . . . . 1.2 . 2 5 government hosp no 2
0.6 0.1 7.7 4.6 29 20 81 1.2 22 2 Forced emesis government hosp no 0
0.9 0.7 5.5 3.1 175 31 61 1.5 24 1 . home yes 35
0.7 0.2 7.9 4.6 13 10 65 1.0 . 2 gastric lavage unknown no 0
. . . . . . . 0.9 . 1 . home yes 3
0.5 0.2 8.1 4.4 14 12 168 0.8 . 1 . home no 0
0.6 0.1 7.0 4.0 28 15 37 1.0 . 2 . private hosp yes 5
. . . . . . . 0.8 . 1 . home no 0
. . . . . . . 0.9 . 1 . home yes 3
1.0 0.2 7.2 4.5 25 16 75 0.9 . 1 . home no 0
0.4 0.1 6.8 4.0 15 10 28 1.2 . 1 . home yes 4























































icuhdu Intubated MethodDecontamination CharcoalGiven @1stcomplication @2ndcomplications @3rdcomplications @4thcomplications @5thcomplications sbpsych psychdiagnosis substabuse
no no others yes hypotension . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes seizures . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes none . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
excluded no none yes none . . . . NOT SEEN excluded none
excluded no none yes Loss of consc. . . . . SOCIAL WORKERexcluded none
excluded no none yes none . . . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes arrythmia hypotension Loss of consc. . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes none . . . . PSYCHIATRISTNORMAL alcohol
excluded no nasogastric tube yes Loss of consc. . . . . PSYCHIATRISTDEPRESSION none
yes yes none yes aspiration pneumonia Deep Vein Th. peritonitis . . PSYCHIATRISTexcluded none
yes yes orogastric tube yes seizures respiratory failure . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no none no none . . . . SOCIAL WORKERexcluded none
excluded no orogastric tube no none . . . . SOCIAL WORKERexcluded none
no no none yes OESO 2A . . . . NOT SEEN excluded none
excluded no none yes none . . . . NOT SEEN excluded none
excluded yes orogastric tube yes Loss of consc. . . . . PSYCHIATRISTPERSONALITY DISORDERnone
excluded yes orogastric tube yes respiratory failure seizures . . . SOCIAL WORKERexcluded none
excluded no none yes unknown . . . . unknown unknown unknown
excluded no none no STOM 1 OESO 1 . . . NOT SEEN excluded none
excluded no orogastric tube yes none . . . . NOT SEEN excluded none
yes no none no STOM 3A OESO 3 FEED JUJENOSTOMY. . NOT SEEN excluded none
excluded no orogastric tube yes none . . . . SOCIAL WORKERexcluded none
excluded no orogastric tube yes cerebellar dysf. . . . . NOT SEEN excluded none
excluded no orogastric tube yes none . . . . NOT SEEN excluded none
excluded no none yes none . . . . SOCIAL WORKERexcluded none
yes no none no unknown . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no none yes none . . . . NOT SEEN excluded alcohol
excluded no none yes delirium . . . . PSYCHIATRISTADJUSTMENT DISORDERnone
excluded no none yes arrythmia hypotension delirium . . PSYCHIATRISTPERSONALITY DISORDERnone
excluded no none no cerebellar dysf. . . . . PSYCHIATRISTMENTAL RETARD none
excluded no orogastric tube yes none . . . . PSYCHIATRISTNORMAL none
excluded no orogastric tube yes none . . . . PSYCHIATRISTMARITAL DISCORD none
excluded no none yes aspiration pneumonia rhabdomyolysis ORAL ULCER . . PSYCHIATRISTunknown none
excluded no nasogastric tube yes Loss of consc. . . . . SOCIAL WORKERexcluded none
yes no none yes seizures fracture . . . PSYCHIATRISTunknown none
excluded no none yes unknown . . . . unknown unknown unknown
excluded no none yes STOM 3A OESO 2A . . . PSYCHIATRISTSCHIZOPHRENIA none
yes no none yes death . . . . unknown unknown unknown
excluded no nasogastric tube yes unknown . . . . unknown unknown unknown
no no none no none . . . . PSYCHIATRISTPERSONALITY DISORDERnone
excluded no orogastric tube yes none . . . . PSYCHIATRISTDEPRESSION alcohol
yes yes orogastric tube no unknown . . . . unknown unknown unknown
excluded no orogastric tube no none . . . . NOT SEEN excluded none
no no orogastric tube yes unknown . . . . unknown unknown unknown
excluded no orogastric tube yes none . . . . PSYCHIATRISTMARITAL DISCORD none
yes yes orogastric tube yes respiratory failure Loss of consc. . . . PSYCHIATRISTunknown alcohol
excluded no orogastric tube yes unknown . . . . unknown unknown unknown
yes yes orogastric tube yes aspiration pneumonia respiratory failure Loss of consc. seizures . PSYCHIATRISTunknown none
excluded no none yes unknown . . . . unknown unknown unknown
yes yes orogastric tube yes respiratory failure Loss of consc. . . . PSYCHIATRISTDYSTHYMIA none




Count % of Total Mean Std. Deviation Minimum Maximum





mid-school and below 0 0.0%



















inter-personal conflict 3 3.4%







Pulse 5 106.80 14.043 86 124
Diastolic BP 5 80.00 15.811 60 100
Systolic BP 5 114.00 11.402 100 130
Respiratory Rate 5 22.40 1.673 20 24
O2 Saturation 5 98.20 1.304 97 100
Temperature 5 98.12 .268 98 99
GRBS 5 107.80 24.325 83 145
GCS <15 0 0.0%
vSodium 5 138.80 1.483 137 141
vPotassium 5 3.660 .2966 3.2 4.0
vHCO3 5 19.80 2.049 18 22
vCalcium 0
vPhosporous 0
Total Bilirubin 1 1.700 . 1.7 1.7
direct Bilirubin 1 .400 . .4 .4
Total Protein 1 7.300 . 7.3 7.3
Albumin 1 4.500 . 4.5 4.5
SGOT 1 19.00 . 19 19
SGPT 1 16.00 . 16 16
Alkaline Phosphatase 1 97.00 . 97 97





Abnormal  CXR 0 0.0%
















Gastric lavage in CMCH
no 3 3.3%
yes 2 2.2%






Major affective disorder 1 2.4%
History of substance abuse
no 3 3.8%
yes 1 1.3%
































































Count % of Total Mean Std. Deviation Minimum Maximum




















2 90.00 8.485 84 96
2 65.00 7.071 60 70
2 95.00 7.071 90 100
2 22.00 2.828 20 24
2 98.00 1.414 97 99
0
2 107.00 18.385 94 120
1 1.2%
2 137.00 1.414 136 138
2 3.600 .4243 3.3 3.9
2 20.50 3.536 18 23
1 4.200 . 4.2 4.2
1 2.00 . 2 2
2 .450 .0707 .4 .5
2 .200 .0000 .2 .2
2 7.850 1.3435 6.9 8.8
2 4.350 .2121 4.2 4.5
2 19.00 2.828 17 21
2 22.50 12.021 14 31
2 47.00 49.497 12 82
2 .850 .0707 .8 .9




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes

























































































Count % of Total Mean Std. Deviation Minimum Maximum























7 94.86 6.309 86 102
7 75.71 9.759 60 90
7 115.71 12.724 100 130
7 23.14 1.952 20 26
7 98.00 1.414 96 100
7 98.00 .000 98 98
5 148.60 53.510 101 226
0 0.0%
6 139.33 3.777 135 144
6 3.650 .2881 3.3 4.0
6 17.33 3.266 13 21
3 8.833 .6807 8.3 9.6
2 4.15 3.606 2 7
5 .800 .5148 .4 1.7
5 .240 .0894 .2 .4
5 8.300 .5916 7.8 9.2
5 4.860 .1673 4.6 5.0
5 19.40 7.503 13 31
5 10.20 5.215 5 18
5 72.20 27.905 36 112
6 .867 .0816 .8 1.0




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes


























































































Count % of Total Mean Std. Deviation Minimum Maximum






























1 141.00 . 141 141
1 3.700 . 3.7 3.7
1 21.00 . 21 21
0
0
1 .400 . .4 .4
1 .200 . .2 .2
1 7.600 . 7.6 7.6
1 4.400 . 4.4 4.4
1 17.00 . 17 17
1 5.00 . 5 5
1 78.00 . 78 78





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




















































































Count % of Total Mean Std. Deviation Minimum Maximum























4 98.50 20.873 68 112
4 77.50 9.574 70 90
4 112.50 5.000 110 120
4 24.50 4.123 20 30
4 97.50 1.732 96 100
4 98.00 .000 98 98
3 134.00 20.298 112 152
2 2.4%
4 138.25 1.708 136 140
4 3.850 .1915 3.6 4.0
4 20.25 2.754 17 23
0
0
1 .400 . .4 .4
1 .200 . .2 .2
1 8.400 . 8.4 8.4
1 4.400 . 4.4 4.4
1 17.00 . 17 17
1 10.00 . 10 10
1 65.00 . 65 65





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes





































































































Count % of Total Mean Std. Deviation Minimum Maximum























3 97.33 27.006 70 124
3 76.67 11.547 70 90
3 126.67 25.166 100 150
3 23.33 3.055 20 26
3 95.67 .577 95 96
3 97.67 .577 97 98
3 110.00 21.517 89 132
1 1.2%
2 145.50 14.849 135 156
2 3.950 .3536 3.7 4.2




1 .200 . .2 .2
0
0
1 16.00 . 16 16
1 10.00 . 10 10
0
1 .800 . .8 .8




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




























































































Count % of Total Mean Std. Deviation Minimum Maximum























2 104.00 22.627 88 120
2 65.00 7.071 60 70
2 105.00 21.213 90 120
2 22.00 2.828 20 24
2 97.00 1.414 96 98
2 98.00 .000 98 98
2 161.00 41.012 132 190
0 0.0%
2 138.50 3.536 136 141
2 3.400 .1414 3.3 3.5
2 20.00 4.243 17 23
0
0
1 .400 . .4 .4
1 .100 . .1 .1
1 8.100 . 8.1 8.1
1 4.900 . 4.9 4.9
1 28.00 . 28 28
1 28.00 . 28 28
1 56.00 . 56 56





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes
































































































Count % of Total Mean Std. Deviation Minimum Maximum























3 138.33 16.503 120 152
3 90.00 .000 90 90
3 143.33 11.547 130 150
3 28.00 4.000 24 32
4 93.50 9.147 80 100
3 100.00 3.464 98 104
3 159.33 55.582 116 222
2 2.4%
4 138.00 2.160 135 140
4 3.550 .2887 3.2 3.9
4 22.25 1.258 21 24
0
0
1 .600 . .6 .6
1 .100 . .1 .1
1 7.000 . 7.0 7.0
1 4.000 . 4.0 4.0
1 28.00 . 28 28
1 15.00 . 15 15
1 37.00 . 37 37





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes






























































































Count % of Total Mean Std. Deviation Minimum Maximum























2 96.00 22.627 80 112
2 65.00 7.071 60 70
2 100.00 14.142 90 110
2 24.00 .000 24 24
2 98.50 2.121 97 100
2 98.00 .000 98 98
2 109.00 16.971 97 121
0 0.0%
2 139.00 .000 139 139
2 3.450 .0707 3.4 3.5































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




















































































Count % of Total Mean Std. Deviation Minimum Maximum























1 80.00 . 80 80
1 .00 . 0 0
1 80.00 . 80 80
1 22.00 . 22 22
1 96.00 . 96 96
1 98.00 . 98 98
0
0 0.0%
1 141.00 . 141 141
1 3.600 . 3.6 3.6































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes

























































































Count % of Total Mean Std. Deviation Minimum Maximum























1 144.00 . 144 144
1 70.00 . 70 70
1 90.00 . 90 90
1 20.00 . 20 20
1 94.00 . 94 94
0
1 166.00 . 166 166
0 0.0%
1 140.00 . 140 140
1 3.700 . 3.7 3.7































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes


























































































Count % of Total Mean Std. Deviation Minimum Maximum























5 114.40 12.280 100 130
5 88.00 13.038 80 110
5 126.00 11.402 110 140
5 26.40 4.561 20 32
5 97.40 1.949 96 100
4 98.00 .000 98 98
4 113.00 10.614 101 126
4 4.7%
5 138.20 4.266 134 143
5 3.440 .7021 2.8 4.6
5 21.40 3.209 18 26
0
0
2 .600 .2828 .4 .8
2 .150 .0707 .1 .2
2 7.600 1.1314 6.8 8.4
2 4.350 .4950 4.0 4.7
2 21.50 9.192 15 28
2 16.50 9.192 10 23
2 51.50 33.234 28 75





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes





























































































Count % of Total Mean Std. Deviation Minimum Maximum























4 114.50 16.763 92 130
4 75.00 12.910 60 90
4 90.00 42.426 30 130
4 22.50 1.915 20 24
4 96.25 1.708 94 98
4 98.00 .000 98 98
4 110.50 18.412 98 137
2 2.4%
4 136.50 .577 136 137
4 3.400 .3651 3.0 3.8
4 21.00 1.414 19 22
1 .800 . .8 .8
0
1 1.000 . 1.0 1.0
1 .300 . .3 .3
1 7.900 . 7.9 7.9
1 4.600 . 4.6 4.6
1 16.00 . 16 16
1 10.00 . 10 10
1 51.00 . 51 51





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes
































































































Count % of Total Mean Std. Deviation Minimum Maximum























9 95.67 18.828 64 124
9 77.78 10.929 60 90
9 115.56 12.360 90 130
9 25.33 3.873 20 32
8 95.38 7.110 78 100
8 98.13 .354 98 99
8 162.25 72.671 76 264
2 2.4%
9 138.11 2.892 135 144
9 3.600 .4243 2.7 4.1
9 19.11 2.147 15 22
1 4.100 . 4.1 4.1
0
3 .700 .1000 .6 .8
3 .167 .0577 .1 .2
3 8.633 1.0970 8.0 9.9
3 4.533 .2517 4.3 4.8
3 82.33 102.051 18 200
3 51.33 68.245 8 130
3 92.67 31.390 68 128
8 .925 .1488 .7 1.1




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes







































































































Count % of Total Mean Std. Deviation Minimum Maximum























3 98.67 11.547 92 112
3 66.67 5.774 60 70
3 103.33 5.774 100 110
3 20.00 .000 20 20
3 97.67 1.155 97 99
2 98.00 .000 98 98
3 97.33 5.508 91 101
1 1.2%
4 139.00 1.826 137 141
4 3.800 .8832 3.2 5.1
4 15.75 4.031 10 19
0
0
2 .650 .3536 .4 .9
2 .450 .3536 .2 .7
2 6.850 1.9092 5.5 8.2
2 3.900 1.1314 3.1 4.7
2 108.00 94.752 41 175
2 23.00 11.314 15 31
2 54.50 9.192 48 61
4 1.025 .3202 .8 1.5




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes

































































































Count % of Total Mean Std. Deviation Minimum Maximum























3 102.33 28.572 82 135
3 76.67 11.547 70 90
3 120.00 26.458 100 150
2 22.00 2.828 20 24
3 94.67 5.774 88 98
2 98.00 .000 98 98
2 135.50 58.690 94 177
0 0.0%
2 135.00 4.243 132 138
2 3.900 .7071 3.4 4.4































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




























































































Count % of Total Mean Std. Deviation Minimum Maximum























2 91.00 7.071 86 96
2 70.00 .000 70 70
2 105.00 7.071 100 110
2 21.00 1.414 20 22
2 95.50 .707 95 96
2 98.00 .000 98 98
2 83.00 2.828 81 85
0 0.0%
2 142.00 2.828 140 144
2 2.900 .4243 2.6 3.2































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes



















































































Count % of Total Mean Std. Deviation Minimum Maximum























2 90.50 9.192 84 97
2 70.00 .000 70 70
2 115.00 21.213 100 130
2 25.00 1.414 24 26
2 97.00 .000 97 97
2 98.00 .000 98 98
2 156.50 45.962 124 189
0 0.0%
2 140.00 1.414 139 141
2 3.700 .5657 3.3 4.1
2 22.50 .707 22 23
1 7.700 . 7.7 7.7
1 3.30 . 3 3
2 .600 .0000 .6 .6
2 .200 .0000 .2 .2
2 8.050 .4950 7.7 8.4
2 4.500 .7071 4.0 5.0
2 1757.50 2123.442 256 3259
2 277.50 347.189 32 523
2 71.00 11.314 63 79
2 .850 .0707 .8 .9




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes
































































































Count % of Total Mean Std. Deviation Minimum Maximum























2 101.00 15.556 90 112
2 70.00 .000 70 70
2 100.00 .000 100 100
2 24.00 .000 24 24
2 97.50 .707 97 98
2 98.00 .000 98 98
2 112.50 20.506 98 127
1 1.2%
2 138.50 2.121 137 140
2 3.200 .0000 3.2 3.2































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes

























































































Count % of Total Mean Std. Deviation Minimum Maximum























2 72.00 11.314 64 80
2 80.00 .000 80 80
2 125.00 7.071 120 130
2 22.00 2.828 20 24
2 88.00 14.142 78 98
2 98.30 .424 98 99
2 137.50 30.406 116 159
0 0.0%
2 137.50 .707 137 138
2 4.150 1.0607 3.4 4.9










2 1.200 .1414 1.1 1.3




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




























































































Count % of Total Mean Std. Deviation Minimum Maximum























1 80.00 . 80 80
1 80.00 . 80 80
1 120.00 . 120 120
1 15.00 . 15 15
1 96.00 . 96 96
1 98.00 . 98 98
0
0 0.0%
1 135.00 . 135 135
1 2.100 . 2.1 2.1































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes














































































Count % of Total Mean Std. Deviation Minimum Maximum























3 140.00 26.153 122 170
3 90.00 45.826 50 140
3 130.00 30.000 100 160
3 30.67 9.018 22 40
3 90.33 8.737 83 100
3 98.00 .000 98 98
3 163.33 46.112 111 198
3 3.5%
3 144.67 9.504 135 154
3 3.767 .7638 3.1 4.6
3 16.33 4.163 13 21
0
0
2 .550 .0707 .5 .6
2 .200 .0000 .2 .2
2 7.600 1.1314 6.8 8.4
2 4.450 .7778 3.9 5.0
2 44.50 2.121 43 46
2 15.50 4.950 12 19
2 92.00 42.426 62 122





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes


























































































Count % of Total Mean Std. Deviation Minimum Maximum























1 122.00 . 122 122
1 90.00 . 90 90
1 160.00 . 160 160
1 20.00 . 20 20
1 98.00 . 98 98
1 98.00 . 98 98
1 126.00 . 126 126
0 0.0%
1 137.00 . 137 137
1 3.100 . 3.1 3.1
1 18.00 . 18 18
1 8.900 . 8.9 8.9








1 1.000 . 1.0 1.0




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes



















































































Count % of Total Mean Std. Deviation Minimum Maximum























11 115.36 12.620 88 135
11 77.27 13.484 60 100
11 116.73 15.932 90 130
11 25.09 3.145 20 32
11 95.91 3.015 88 99
10 98.36 .672 98 100
10 124.40 46.805 81 239
3 3.5%
11 140.91 2.700 137 145
11 3.545 .6758 3.0 5.5
11 19.00 4.583 8 24
0
0
2 3.750 4.5962 .5 7.0
2 .150 .0707 .1 .2
2 8.350 .4950 8.0 8.7
2 5.150 .9192 4.5 5.8
2 44.00 18.385 31 57
2 12.50 3.536 10 15
2 64.00 22.627 48 80





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes






























































































Count % of Total Mean Std. Deviation Minimum Maximum























7 92.43 34.727 24 130
7 75.71 9.759 60 90
7 112.86 14.960 90 130
7 24.00 2.828 22 30
7 96.14 4.947 85 99
7 98.00 .000 98 98
6 106.17 10.028 95 124
3 3.5%
7 141.14 4.298 137 147
7 3.614 .3976 3.2 4.2
7 21.29 2.563 17 24
0
0
1 .600 . .6 .6
1 .100 . .1 .1
1 7.700 . 7.7 7.7
1 4.600 . 4.6 4.6
1 29.00 . 29 29
1 20.00 . 20 20
1 81.00 . 81 81
7 .943 .2225 .7 1.2




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes




































































































Count % of Total Mean Std. Deviation Minimum Maximum




















1 104.00 . 104 104
1 80.00 . 80 80
1 110.00 . 110 110
1 26.00 . 26 26
1 98.00 . 98 98
1 98.00 . 98 98
1 137.00 . 137 137
1 1.2%
1 139.00 . 139 139
1 3.800 . 3.8 3.8































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes





















































































Count % of Total Mean Std. Deviation Minimum Maximum























1 99.00 . 99 99
1 70.00 . 70 70
1 110.00 . 110 110
1 24.00 . 24 24
1 99.00 . 99 99
1 98.00 . 98 98
1 84.00 . 84 84
0 0.0%
1 141.00 . 141 141
1 3.600 . 3.6 3.6
1 22.00 . 22 22
0
0
1 .700 . .7 .7
1 .200 . .2 .2
1 7.400 . 7.4 7.4
1 4.400 . 4.4 4.4
1 19.00 . 19 19
1 8.00 . 8 8
1 55.00 . 55 55





















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes

























































































Count % of Total Mean Std. Deviation Minimum Maximum























2 140.00 22.627 124 156
2 80.00 .000 80 80
2 120.00 .000 120 120
2 34.00 19.799 20 48
2 95.50 .707 95 96
2 99.65 2.333 98 101
1 83.00 . 83 83
0 0.0%
2 137.50 .707 137 138
2 3.350 .9192 2.7 4.0
2 13.50 4.950 10 17
0
0
1 .900 . .9 .9
1 .200 . .2 .2
1 8.600 . 8.6 8.6
1 4.500 . 4.5 4.5
1 1779.00 . 1779 1779
1 1460.00 . 1460 1460
1 118.00 . 118 118
2 1.350 .2121 1.2 1.5




















Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes





































































































































Gastric lavage in CMCH
no
yes







History of substance abuse
no
yes































ANNEXURE 1:STUDY PROFORMA : A CLINICAL DESCRIPTIVE STUDY ON 
POISONNG IN CMC VELLORE 




Name      Hospital Number 
 
Age      Sex  male / female 
 
Address     Education 









 No of tablets/ ML (if liquid) / Weight : 
 
 Strength of each tablet / Concentration: 
 
 Total Dose: 
 





Source of Poison: 
 Home/ Surroundings 
 Patient already taking regulary 
 Another family member taking regularly 
 Procured from goods store/ pharmacy 
 
Was the poison taken directly/ diluted? 
Co- ingestants 
  Water 
 Alcohol 
 Other solvent 
 




Conflcit with family members 
 
Relationship problems with partner 
Dissatisfaction with school performance 
 
ANNEXURE 1:STUDY PROFORMA : A CLINICAL DESCRIPTIVE STUDY ON 
POISONNG IN CMC VELLORE 




Job related- dissatisfaction/ unemployment 
 





 B] Was the intention  
a. deliberate 
  b. accidental 
  c. other 
 





D] Is this the first attempt 
  If not, no of previous attempts: 
  Was the previous attempt  
 
 E] Time of Ingestion     Date  time 
Time of Presentation to hospital   Date   time 
 
 
TREATMENT GIVEN BEFORE COMING TO CMCH 
 
 Yes/ No   Date  time  delay (hrs) 
 
 If yes, what treatment?  
  
 Forced emesis/ Gastric lavage / Activated Charcoal  
 
 Specific Antidote   Name   Number of 
doses 
 Where was the treatment administered? 
Home / Government Hospital / Private Hospital / 
ANNEXURE 1:STUDY PROFORMA : A CLINICAL DESCRIPTIVE STUDY ON 
POISONNG IN CMC VELLORE 





VITALS ON PRESENTATION 
 
  BP  PR  RR  TEMP 
  




0.ASYMPTOMATIC / 1.VOMITING / 2.DIARRHOEA / 3.ABDOMINAL PAIN/ 
4.SALIVATION / 5.SWEATING / 6.BLURRED VISION / 7.URINARY 
INCONTINENCE / 8. BREATHING DIFFICULTY / 9.WEAKNESS / 
10.SEIZURES / 11.BLEEDING / 12.GIDDINESS / 13.ALTERED SENSORIUM 
/ 14.SEDATION / 15.CHARACTERISTIC SMELL/ (CORROSIVE): 
17.OROPHARYNGEAL PAIN/ 18. ODYNOPHAGIA/ 19. DYSPHAGIA /20. 






ANNEXURE 1:STUDY PROFORMA : A CLINICAL DESCRIPTIVE STUDY ON 
POISONNG IN CMC VELLORE 





1. DIAPHORESIS / 2. LUNG CREPITATION / 3. SALIVATION / 4. 
FASCICULATIONS / 5. MUSCLE WEAKNESS / 6. SINGLE BREATH 
COUNT / 7. PARADOXICAL BREATHING / 8. ABDOMINAL 
TENDERNESS / 9. PERITONISM/ 10. DROOLING /11. STRIDOR /12. 




CHEST X RAY 
 
ECG  
Rate  PR  QTC  other 
 
ABG ph CO2 O2 stdHCO3- StdBE  LAc  
 
Electrolytes Na K HCO3  Ca Po4 
 








 No of hours after ingestion: 
Gastric Lavage: y/n Orogastric tube  Ryle’s Tube  
 Did the patient require intubation? 
Poison detected physically in lavage fluid? Y / n 
 Complication: 
Activated charcoal: y/n  strength: Total dose: 
 
Skin decontamination:  Clothing changed: 
